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Christopher John Oldfield 
INTRINSICALLY DISORDERED PROTEINS IN MOLECULAR RECOGNITION AND 
STRUCTURAL PROTEOMICS 
 
Intrinsically disordered proteins (IDPs) are abundant in nature, being more prevalent in 
the proteomes of eukaryotes than those of bacteria or archaea.  As introduced in Chapter I, these 
proteins, or portions of these proteins, lack stable equilibrium structures and instead have 
dynamic conformations that vary over time and population.  Despite the lack of preformed 
structure, IDPs carry out many and varied molecular functions and participate in vital biological 
pathways.  In particular, IDPs play important roles in cellular signaling that is, in part, enabled by 
the ability of IDPs to mediate molecular recognition.  In Chapter II, the role of intrinsic disorder 
in molecular recognition is examined through two example IDPs: p53 and 14-3-3.  The p53 
protein uses intrinsically disordered regions at its N- and C-termini to interact with a large 
number of partners, often using the same residues.  The 14-3-3 protein is a structured domain that 
uses the same binding site to recognize multiple intrinsically disordered partners.  Examination of 
the structural details of these interactions highlights the importance of intrinsic disorder and 
induced fit in molecular recognition.  More generally, many intrinsically disordered regions that 
mediate interactions share similar features that are identifiable from protein sequence.  Chapter 
IV reviews several models of IDP mediated protein-protein interactions that use completely 
different parameterizations.  Each model has its relative strengths in identifying novel interaction 
regions, and all suggest that IDP mediated interactions are common in nature.   In addition to the 
biologic importance of IDPs, they are also practically important in the structural study of proteins.  
The presence of intrinsic disordered regions can inhibit crystallization and solution NMR studies 
of otherwise well-structured proteins.  This problem is compounded in the context of high 
throughput structure determination.  In Chapter III, the effect of IDPs on structure determination 
by X-ray crystallography is examined.  It is found that protein crystals are intolerant of intrinsic 
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disorder by examining existing crystal structures from the PDB.  A retrospective analysis of 
Protein Structure Initiative data indicates that prediction of intrinsic disorder may be useful in the 
prioritization and improvement of targets for structure determination. 
 
Sarath Chandra Janga, Ph.D., Chair 
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I. INTRODUCTION 
Intrinsically disordered proteins (IDPs) 
The classic model of protein function is the sequence-structure-function paradigm; a 
protein's sequence determines the protein's three-dimensional structure (1)⁠, and the protein's 
structure determines the protein's function, via the lock-and-key mechanism (2)⁠.  This view likely 
arose because enzymes were the primary focus of early functional and structural characterizations 
of proteins.  Enzymes were convenient targets for study because their activities could be precisely 
quantified and related to physical characteristics of the enzyme, including protein structure.  
Many elegant studies have related the details of protein structure directly to function, e.g. the 
catalytic activity of α-chymotrypsin (3) and the allosteric mechanism of hemoglobin (4).  
Although contemporary structural biology appreciates the role of dynamics in protein function 
(5), these dynamics are relative to a stable equilibrium, and so the basic principle of sequence-
structure-function has and still remains true for enzymes.  However, not all proteins are enzymes. 
Contrary to the classic model of protein function, intrinsically disordered proteins (IDPs) 
function without the prerequisite of a stable structure (6)⁠.  The conformations of IDPs vary in 
time and over populations (7), and intrinsic disorder is encoded by the sequence of amino acids 
(8), similar to the encoding of specific protein structure in sequence.  The extent of intrinsic 
disorder varies from protein to protein (here, the term IDP is used loosely to refer both to proteins 
that are completely intrinsically disordered and those that consist of a mixture of ordered and 
disordered residues): from completely disordered proteins, to mostly disordered proteins with 
local regions of order, to mostly ordered proteins with local regions of disorder, to completely 
ordered proteins (9). Several authors have investigated the functional repertoire of IDPs (7, 10, 
11) ⁠, where one common functional indication is molecular recognition. 
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Physical characteristics 
IDPs have been experimentally characterized by a variety of methods, each with their 
own strengths and weaknesses.  The high resolution methods, X-ray crystallography and nuclear 
magnetic resonance (NMR), have the capability to characterize each residue of a protein as either 
disordered or ordered.  Other lower resolution methods, such as circular dichroism and small 
angle X-ray diffraction, can characterize the relative content of disordered residues in a protein.  
Although lower resolution methods cannot provide a precise residue-by-residue characterization 
of a protein, they can provide high level characterizations that can help to understand the 
structural state of a protein.  Further, low resolution methods can complement each other, e.g. 
combination of circular dichroism, limited proteolysis, and hydrophobic dye binding in 
characterizing the function of the molten globule clusterin (12), and be complemented by 
computational studies that can provide further insights, e.g. the combination of mass 
spectroscopy-resolved limited proteolysis and intrinsic disorder prediction to identify intrinsically 
disordered regions in XPA (13).  Also, for proteins containing both order and disorder, use of 
both high and low resolution methods in concert can provide an improved overview of the spatial 
relationships between the ordered and disordered regions, e.g. combining NMR with small angle 
X-ray diffraction as used for HMGB1 (14) and 4EBP1 (15). 
In the X-ray crystal structures of many proteins, some residues cannot be modeled due to 
the absence of corresponding electron density.  In fact, the majority of known IDP regions have 
been identified from regions of missing density X-ray crystal structures (16).  While rich in 
quantity, the quality of this characterization, in general, is poor.  Missing density is not positive 
identification of disorder; rather, it only identifies regions that do not share the same lattice 
symmetry with the rest of the protein structure, where disorder is only one of many possible 
reasons for a lack of symmetry (other reasons are discussed in Chapter III).  Some alternative 
methods for the solution of protein crystal structures have been developed that can give positive 
evidence of conformational disorder (17, 18), but these are not commonly used nor universally 
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applicable.  Therefore, missing density should be viewed as correlated with IDP regions and not 
as definitive identification of IDP regions. 
In contrast, several NMR experiments can not only give positive evidence for IDPs and 
IDP regions, they can also provide detailed information about the dynamics of each intrinsically 
disordered residue.  In this regard, the 1H-15N hetero nuclear NOE experiment provides direct 
evidence for intrinsic disorder at the per-residue level (19).  This experiment measures restriction 
of motion of backbone amide groups relative to the entire molecule, where a restrained backbone 
amide is strong evidence that a residue is ordered and an unrestrained backbone amide is strong 
evidence that a residue is disordered.  Furthermore, a disordered region with conformational bias 
can be detected by this method, which is particularly compelling when combined with other 
evidence.  For example, the IDP p27-KIP1 binds to the cyclin-CDK complex using two 
disordered regions separated by a third disordered linker region.  This linker was shown to have 
significant structural bias toward helix through a combination of 1H-15N hetero nuclear NOE and 
chemical shift biases, where the latter gives an indication of secondary structure (20).  Later work 
showed that this conformational bias is vital to the kinetics of the p27-cyclin/CDK interaction 
(21).  While the 1H-15N hetero nuclear NOE experiment is very powerful at characterizing 
dynamics, it is a less common use of protein NMR than the solution of protein structures.   
Solved NMR structures can also be used to identify intrinsically disordered residues in an 
analogous way to X-ray structures.  Since NMR structures are underdetermined – fewer 
constraints are available than degrees of freedom in the protein – it is a common practice to report 
multiple models that fit the available NMR-derived constraints equally well (22).  In these 
multiple structures, under- or un-constrained regions are often apparent through large variation in 
conformation.  These regions have been shown to closely correspond to regions of missing 
density in crystal structures of the same protein (23).  However, identification of disorder through 
conformational variability in NMR models has analogous drawbacks to identification of disorder 
by missing density in X-ray structures; several experimental and procedural complications can 
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give rise to lack of NMR constraints (22).  Therefore, similar to missing density, an under-
constrained region in a NMR structure is not a definitive indication of intrinsic disorder. 
Several experimental methods can be used for a lower resolution characterization of 
intrinsic disorder.  For example, limited proteolysis can identify whether protease cut sites reside 
in structured or unstructured regions.  Proteases hydrolyze sequence specific sites, but the rate at 
which those sites are hydrolyzed is directly related to whether they are ordered or disordered, 
where the rate of hydrolysis of disordered sites is orders of magnitude faster than the rate of 
ordered sites (24).  By resolving the proteolysis reaction over time and identification of 
proteolysis fragment via mass spectrometry, the relative cut rates of each site can be determined 
and thereby the order/disorder state of each cut site (13).  The number of sequence-specific cut 
sites limits the resolution of this method but can be increased by using multiple proteases. 
Another important experiment for the identification of IDPs is circular dichroism (CD).  
This experiment measures the differential absorption of left and right circularly polarized light, 
which is strongly dependent on the local environments of chiral centers in a molecule.  Since each 
residue (excepting glycine) has a chiral center at the α-carbon, the far-UV CD spectrum of a 
protein is highly dependent on conformation of the protein backbone.  Secondary structure types, 
α-helix and β-sheet, give distinct CD spectra, and lack of structure, so called random coil, also 
gives a distinct spectrum.  Many IDPs have been identified by their distinct CD spectra (25).  CD 
is an invaluable tool for initial, high level characterization of IDPs.  However, some types of IDPs 
– molten globules – can exhibit high a high content of secondary structure, so other additional 
methods are required to characterize these proteins. 
Finally, gel filtration and small angle X-ray scattering  (SAXS) are experiments that can 
provide high level characterization of proteins as ordered or disordered.   Gel filtration provides a 
relative measure of a protein's size in solution rather than its mass (26).  Since IDPs are somewhat 
more extended in solution than ordered proteins, a protein's solution size, combined with its 
molecular weight, can be used as positive evidence that a protein is disordered (27).  SAXS also 
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measures the solution dimensions of protein but in much more detail than gel filtration.  In the 
case of ordered proteins, SAXS can be used to obtain a low resolution structure (28), but for 
highly dynamic IDPs, possible conformations are too degenerate and the shape of the 
conformational ensemble can only be described at a qualitative level (29).  However, SAXS is 
very sensitive to residual structure in IDPs (29), and in the case of IDPs that contain partial 
structure or a biased conformational ensemble, a low resolution density map can be determined 
for constrained portions of the IDP (15). 
Many more methods for physical characterization of IDPs have been developed (30, 31), 
including deuterium exchange (32) and spin labeling (33).  All of these methods provide a unique 
perspective on the order-disorder state of a protein, probing different structural and chemical 
characteristics of protein structure.  No single method gives a complete picture of the 
conformational characteristics of IDPs in the same way that an X-ray structure characterizes an 
ordered protein, but through application of multiple methods much can be learned (34).  The 
physical characterization of IDPs is a field that is still evolving, and much of that evolution 
involves combination of both experimental and computational techniques, e.g. the combination of 
NMR and ensemble methods (35), and the combination of limited proteolysis and prediction of 
intrinsic disorder (13). 
Sequence characteristics 
Similar to the way a specific three dimension structure is encoded in the sequence of an 
ordered protein, the sequence also encodes a higher level, namely the ordered or disordered state 
of the protein.  The relationship between intrinsic disorder and protein sequence was first noted in 
the case of nucleic acid associated proteins, which are rich in disorder and carry a relatively high 
net positive charge (36).  Many subsequent studies have found that disordered proteins are also 
generally enriched in hydrophilic residues and depleted in hydrophobic residues, relative to 
structured proteins (37).  In addition to these general biases, disordered regions are highly 
enriched in proline (8), likely because it disrupts regular secondary structure, and depleted in 
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cysteine (8), likely because of its ability to stabilize structure by forming crosslinks.  
Additionally, while it might be presumed that the compositions of IDPs would be very similar to 
the compositions of protein surfaces, there are some notable differences (38).  One difference is 
that surfaces are generally enriched in all charged residues, but, compared to protein surfaces, 
IDPs are significantly less enriched in arginine and aspartic acid.  Another difference is that IDPs 
are significantly depleted in all aromatic residues, but surfaces show little or no depletion of 
tryptophan and tyrosine and even a slight enrichment in histidine.  The chemical and structural 
reasons for these asymmetries are currently not clear but likely relate to the hydrogen bonding 
potential of these three aromatics.  Another notable feature of many disordered proteins is a low 
complexity sequence (8); many disordered proteins use a limited number of amino acids in their 
sequences.  However, low complexity is not a requirement for a sequence to be disordered since 
many IDPs have a comparable complexity to ordered proteins (8). 
The compositional biases of IDPs are an indication that sequence encodes for disorder, 
and additional evidence is provided by prediction of disorder from sequence.  At the level of 
predicting disorder for an entire protein sequence or region, the mean absolute net charge and 
mean hydropathy separate ordered and disordered proteins very well (37), where disordered 
proteins tend to have a larger net charge and a lower hydrophobicity.  The charge-hydropathy 
approach was also applied to per-residue prediction with good results (39), though more 
sophisticated approaches are more accurate.  The first application of machine learning to 
prediction of intrinsic disorder from protein sequence was a neural network trained on several 
sequence attributes calculated on a small local window (40).  A generalized extension of this 
predictor has good accuracy in predicting novel regions of intrinsic disorder (8).  Subsequently, 
many predictors of intrinsic disorder from protein sequence have been developed using a variety 
of architectures (41), and prediction accuracy has reached a high level, as measured by objective 
evaluation (42).  This high level prediction accuracy is due in no small part to the increasing 
number of well characterized IDPs and IDP regions, many of which have been collected into the 
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Database of Protein Disorder (DisProt) (16).  The high level of prediction accuracy not only 
demonstrates the principle that intrinsic disorder is encoded by protein sequence, but provides a 
valuable research tool for the discovery of novel IDPs and investigating the role of IDPs in 
biology. 
Functional characteristics 
Application of disorder predictors to proteomes in all domains of life have helped provide 
insight into the biological roles of IDPs, and a significant amount of experimental data has been 
amassed on the novel and varied mechanisms by which IDPs carry out these roles (43).  
Correlations of functional annotations with disordered predictions (10, 11, 44) consistently 
indicate that intrinsic disorder plays a central role in cellular signaling.  This idea is supported by 
the importance of disorder in the regulation of transcription (45) and some key signaling pathway 
and proteins (46–48).  Also, eukaryotes are rich in intrinsic disorder relative to prokaryotes and 
archaea, which correlates with the increased complexity of signaling in eukaryotes (49).  
Signaling roles are fulfilled by IDPs' ability to mediate and regulate molecular recognition.  
Additionally, many IDPs have entropy-based functions; they have roles that rely directly on 
maintenance of their conformational heterogeneity.  Signaling and entropy-based functions are 
not mutually exclusive, which will be illustrated by an example.  
Many IDPs have been found to mediate interactions with other macromolecules, both 
nucleic acid and protein.  Nucleic acid binding was one of the first functions associated with IDPs 
(36).  Transcription factors (45), histones (50), and ribosomal proteins (51) are all rich in intrinsic 
disorder.  Often the nucleic binding interface itself is disordered, e.g. Myc (52) and HMG-I(Y) 
(53), which is consistent with a high positive charge density to complement the high negative 
charge of nucleic acid backbones.  In others, the nucleic acid binding domain is ordered, but 
disorder plays other important roles in other portions of these proteins (54), such as interactions 
with other proteins.  Many examples of intrinsic disorder mediating interactions with partner 
proteins have been reported (7, 55).  IDPs use fewer residues than ordered proteins to achieve 
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interfaces of comparable size (56) meaning that IDPs make efficient scaffolds (57) – scaffolds 
organize a large number of proteins to achieve higher level functions (58) and increase signaling 
efficiency (59).  Additionally, the conformational flexibility of IDPs allows them to bind to 
multiple partners with distinct recognition sites (60).  This ability to facilitate multiple specificity 
has been found in many IDPs (61) and is a focus of Chapter II. 
The signaling functions of IDPs are regulated in several ways. Signaling via molecular 
recognition is often regulated via post-translational modifications, and the sites of many types of 
post translational modification are preferentially located in IDP regions (62–64).  Post-
translational modifications provided a direct mechanism for modulating signaling interactions 
mediated by IDPs, where modifications may directly participate in or disrupt an interaction (60), 
or induce or disrupt conformations required for an interaction (65).  Also, mRNA encoding for 
IDP regions are preferential sites of alternative splicing (66), providing another mechanism for 
regulation of IDP proteins.  Finally, other regulation mechanisms, such as protein degradation and 
translation regulation, have also been correlated with IDPs (67), although the mechanistic role of 
IDPs in these modes of regulation is not clear.  The combined roles of IDPs in molecular 
recognition and regulation strongly suggest IDPs as a central feature of cellular signaling. 
In addition to signaling functions, many IDPs perform functions that are quintessentially 
intrinsically disordered.  These are functions that arise from the conformational heterogeneity of 
disordered proteins, which have been called entropy-based functions (7), and span a wide variety 
of mechanisms, which are illustrated here by a few examples.  For example, the Shaker voltage 
gated potassium channel protein consists of a transmembrane channel subunit and an intrinsically 
disordered plug subunit (68).  The duration of activation of the channel is determined by how 
long the plug subunit takes to rebind to the channel domain once it is displaced; the disordered 
plug domain acts as an entropic clock, where the duration of channel opening is related to the 
search space of the plug domain (69).  For another example, the nuclear pore complex contains 
several proteins with long disordered tails consisting of FG repeats (70).  These fill the wide 
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channel of the pore, which allows a free flow of ions but prevents larger molecules from freely 
passing through due to energy required to restrict the entropic freedom of the disordered tails 
(71).  A final example is the neurofilament H protein that plays a role in maintaining axon 
structure.  This IDP is highly phosphorylated and forms an extended bristle.  Multiple bristles 
arising from multiple subunits form a brush around each neurofilament, preventing the axon from 
collapsing, with electrostatic repulsion enhancing the excluded volume effects of the brushes 
(72).   
Molecular recognition, regulation, and entropic functions are not mutually exclusive, 
which is demonstrated by the example of the Sic1 protein.  Sic1 is an intrinsically disordered 
protein (73) that inhibits cell cycle progression until Sic1 is inactivated by proteolytic degradation 
by the SCF complex (74).  Recognition of Sic1 by SCF is mediated by Cdc4, which recognizes a 
phosphorylated motif.  Sic1 contains 9 suboptimal copies of the Cdc4 recognition motif (73), and 
phosphorylation of multiple suboptimal motif instances is required for high affinity binding of 
Sic1 by Cdc4 (75).  The requirement for multiple phosphorylations is remarkable because Cdc4 
only has a single motif recognition site (75).  Experiment (76) and modeling (77) results have 
indicated that tight binding is achieved through long range electrostatic interactions and transient 
interaction of multiple phosphorylated sites on Sic1 with the single Cdc4 motif binding interface, 
which is enabled by the intrinsic disorder of Sic1.  Sic1 embodies many of the hallmark features 
of intrinsically disordered proteins: regulation by post-translational modification, molecular 
recognition, and function through conformational diversity. 
There are also significant evolutionary implications of intrinsic disorder.  In agreement 
with indications of the role of intrinsic disorder in cellular signaling, intrinsic disorder is over 
represented in eukaryotic organisms, relative to archaea or bacteria (49).  Also, it has been 
suggested that the lack of requirement for order structure implies that IDPs should be more 
tolerant of random mutation due to genetic drift than ordered proteins, and for many IDPs this is 
the case (78, 79).  Furthermore, a specific sequence is not required for function of some IDPs, 
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where the primary functional requirement appears to be amino acid composition (80).  However, 
many other IDPs appear to be more conserved than expected (78, 79), possibly due to functional 
constraints on these proteins.  Indeed, several well characterized domain families have been 
found to contain conserved disordered regions (81) or even to be entirely disordered (82), 
suggesting that intrinsic disorder is positively selected for in evolution. 
Structural characteristics 
Much recent work has focused on describing the conformational characteristics of 
intrinsically disordered proteins at various levels of resolution.  At the coarsest level of resolution, 
the order-disorder continuum has been defined (83).  This formalism quantifies the relative 
conformational diversity of a protein as a single number, which represents the number of 
structures required to represent the protein's conformational diversity, where a value of 1 
indicates a single, stable equilibrium structure, and 0 represents a protein that requires an infinite 
number of structures to describe its diversity, which is not observed in practice.  At finer levels of 
resolution, ensemble modeling methods have been developed (35, 84).  These methods derive a 
set of static structures that in aggregate represent the solution structure of intrinsically disordered 
proteins.  A set of structures, combined with their respective relative populations, can be used to 
model experimental data and predict protein properties.  The finest resolution is provided by 
molecular dynamics simulations, which attempt to simulate the details of the behavior of proteins 
in solution (85).  Disordered proteins are particularly difficult to address with these methods 
because the large scale motions they undergo are on a very large time scale, requiring an 
enormous amount of computational resources to simulate (86).  Rather than direct simulation, 
approximation methods (87) have been very successful sampling the full conformational diversity 
of intrinsically disordered proteins.  
The picture of the solution characteristics of IDPs has been largely determined in broad 
strokes, and is highly dependent on sequence properties and context.  Sequence properties that 
affect solution conformations are primarily hydrophobicity and net charge; where hydrophobic 
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low charge sequences are more collapsed and hydrophilic, highly charged sequences are more 
expanded.  In fact, the hydrodynamic radius of peptides can be modeled directly by these 
properties (88).  The idea of collapsed IDPs composed of hydrophilic, uncharged residues is 
somewhat paradoxical, since one might expect that these residues should prefer to interact with 
water and form expanded structures.  However, recent evidence has shown that water is a poor 
solvent for the protein backbone, which drives these IDPs to collapse (89), and only in the 
presence of significant charge-charge repulsion do sequences form expanded structures (90).  
Even the poly-glutamine sequence forms a collapsed rather than an extended form (89), likely 
from the just mentioned backbone effects and also because the amide groups prefer to hydrogen 
bond with each other rather than with water.  Additionally, charge distribution plays a large part 
in the expansion of IDP sequences, where a highly asymmetrical charge distribution, e.g. acidic 
residues at the N-terminus and basic residues at the C-terminus, will cause a sequence to be less 
expanded than expected (91).  These observations suggest that the solution behavior of IDPs can 
be fine-tuned by nature through coarse compositional changes. 
The context dependence of intrinsic disorder is often functional.  Many examples of IDPs 
undergoing a disorder-to-order transition on binding have been determined, and so intrinsic 
disorder is contextually dependent on the absence of these binding partners.  This contextual 
dependence has inspired some to suggest that disorder is only as relevant to biology as protein 
folding, i.e. the bound state of these proteins is biologically active while the unbound state is not, 
and they prefer the nomenclature “proteins awaiting partners” to “IDPs” (92).  However, this 
view simply ignores the many IDPs with entropic functions.  Additionally, for IDPs that do bind 
to partners this view re-emphasizes the sequence-structure-function paradigm at the expense of 
consideration and understanding of the unbound state.  The practical importance of the unbound 
state of IDPs is demonstrated by the development of small molecule inhibitors that directly target 
the unbound, disordered states of IDPs (93).  Furthermore, maintained intrinsic disorder can play 
an integral role in binding, as in the case of Sic1.  The more interesting question is not necessarily 
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the structures formed when IDPs bind to partners, but how IDPs recognize partners and the 
functional implications of the disordered state. 
Disorder-to-order transitions (DOTs) 
For IDPs, molecular recognition is often concomitant with folding, where the IDP 
undergoes a DOT (94).  IDPs have been found to bind all types of biological molecules, including 
proteins, nucleic acids, small molecules, and various ions (7).  As a consequence of folding and 
binding, the structures of IDPs with molecular interaction functions in complex with their 
partners can be determined experimentally via X-ray crystallography or NMR spectroscopy.  For 
example, see (94) for examples of IDPs in complex with their partners.  Also, covalent 
modifications, such as phosphorylation or acetylation, can also induce a DOT, a process that is 
thought to be important for signaling and regulation (6, 94).  Finally, intrinsically disordered 
regions can become structured due to crystallization, particularly if they participate in crystal 
contacts (95), which are low affinity contacts that stabilize the crystal lattice.   
Between biologically relevant interactions, covalent modifications, and artificial factors, 
there are several factors that can cause an IDP to appear as well ordered in structure 
determination experiments.  This suggests that, at least potentially, there are a significant number 
of IDPs with structures in the PDB.  This has significant implication for structural biology 
methods that interpret proteins as rigidly structured or moderately flexible, such as homology 
modeling and docking.  This also has implications for bioinformatics, particularly prediction of 
intrinsic disorder from sequence.  Currently, the presence of DOT regions is appreciated in the 
field.  Unfortunately, since no reliable methods are available to identify these regions, this 
appreciation usually translates to exclusion of all ordered proteins that may contain DOT regions, 
namely all complex structures.   
Computational analysis of DOTs 
Several approaches have been used for examining DOT regions in experimentally 
determined protein structures.  In comparative structural analysis methods (96–98), multiple X-
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ray crystal structures of the same or similar protein are compared.  Since regions of missing 
density in X-ray crystal structures are indicative of an intrinsically disordered region, DOT 
regions are inferred where a region is present in one crystal structure but absent in another. 
Structural attributes have also been used to examine DOT regions (99, 100), where static 
parameters of the protein structure are used to characterize these regions.  Finally, a diverse set of 
sophisticated modeling methods has been brought to bear to investigate protein flexibility and 
intrinsic disorder (101–105).  
Comparative analysis 
Several groups have studied DOT regions in known protein structures by comparative 
structural analysis.  Le Gall et al. (96) mapped protein sequences in PDB to reference sequences 
in the SwissProt database.  DOTs were inferred from regions of defined density and regions of 
missing density that map to the same region of reference sequence structures.  This procedure 
identified a large number of DOT residues, but the prevalence of these residues is difficult to 
assess because of how the data are reported.  In a similar study, Zhang et al. (97) examined 
proteins with multiple structures in PDB and extracted regions that that were disordered in at least 
one structure but ordered in at least one other structure.  These authors found 2,819 DOT regions 
(Zhang et al. call these regions “dual personality fragments”; the difference between this 
interpretation and the DOT interpretation is semantic) in 1,535 identical protein clusters, which 
corresponds to at least one DOT region in 45% of proteins with more than one structure in PDB.  
Zhang et al. demonstrated that DOT regions are fairly common in the PDB, but neither study 
attempted to link DOT regions directly with a causal factor, such as molecular interactions or 
crystal contacts. 
A study by Fong et al. (98) focused on DOT regions in conserved binding modes 
(CBMs).  CBMs are a set of protein domain-domain interfaces that have been filtered for artificial 
or otherwise spurious interactions by selecting only those interactions between domain families 
that have been observed in multiple protein structures (106).  Structures with interactions 
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corresponding to CBMs were evaluated for DOTs by pairing these structures with structures of 
the monomeric form of the protein, an approach similar to that of Zhang et al.  Unfortunately 
Fong et al. do not report the raw results of this analysis and instead report the results of a cautious 
statistical test for the bias of interactions' residues to be DOT residues. Despite this cautious 
approach, they found that 42-75% of interfaces show a significant bias toward DOT residues, 
depending on the dataset.  However, many DOT regions were not accounted for by interactions, 
and many other DOT regions were found that are ordered in the monomeric structure and 
disordered in the complex structure, meaning that only a fraction of the DOT regions have causal 
indications in this study. 
While comparative structural analysis is a useful method for identifying DOT regions in 
protein structures, it suffers from reliance on reference monomers.  The fundamental difficulty is 
that reference monomers are not available for the majority of protein-protein, protein-nucleic 
acid, and protein-small molecule complexes.  This suggests that there may be far more DOT 
regions involved in molecular interactions than comparative analysis suggests.  The availability 
of reference monomers may even be biased against DOT containing proteins, since the presence 
of disorder is likely to be a confounding factor in protein crystallization.  Furthermore, there are 
often many contextual differences between the complex structure and reference structure that 
complicate a direct interpretation of the differences between them.  For instance, since the 
contents of the structures differ, there will nearly always be differences in crystallization 
conditions and crystal packing, both of which can induce DOTs.  Additionally, analysis can 
become quite complex if all the constituents of crystal structure, e.g. additional domains, multiple 
binding partners, and small molecules are considered.  
Structural analysis 
A more direct approach to identifying DOT regions in protein structure is through 
structural analysis.  The underlying hypothesis of this approach is that the structures of DOT 
regions and that of ordered regions differ in some significant respect that is detectable through 
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analysis of the protein's structure.  Two groups have taken this approach to DOTs in protein 
structures. 
Gunasekaran et al. studied the special case of an entire chain in a protein structure 
undergoing a DOT (100).  From the literature, the authors constructed a set of complexes 
involving disordered proteins and complexes involving ordered proteins, and then they examined 
these two sets for structural attributes that distinguish ordered proteins from disordered proteins.  
The authors reported two primary attributes: normalized surface area of the protein, calculated 
disregarding the other constituents of the complex, and normalized interface area, calculated as 
the difference between the protein's surface area with and without other complex constituents.  
Both parameters are normalized by the number of residues in the protein.  They found that the 
disordered proteins in their set were distinguished from the ordered proteins by both a 
significantly greater normalized surface area and a significantly greater normalized interface area.  
Mohan et al. also studied the special case of entire protein chains undergoing a DOT (99).  
However, the focus of this work was Molecular Recognition Features (MoRFs), which are short 
DOT regions within a longer region of disorder that are responsible for molecular recognition.  
Because these are short regions within a longer region of intrinsic disorder, the structures of 
complexes involving MoRFs contain only this short region bound to a partner.  Since there are 
only very few folded domains fewer than 70 residues in length, all proteins with a defined density 
shorter than this length and bound to a longer protein were selected from PDB and manually 
verified as lacking globular structure.  This procedure found 372 DOT proteins.  The DOT 
proteins found by this procedure were also consistent with the observations of Gunasekaran et al., 
with relatively large normalized surface and interface areas. 
Both of these studies demonstrated that structural analysis methods are useful for 
identifying DOTs.  However, both were limited to the case of entire proteins undergoing a DOT.  
For the more general case of DOTs that occur in the context of otherwise ordered proteins, such 
loops, termini, or inter-domain regions, the Mohan et al. method is inapplicable by definition and 
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the Gunasekaran et al. method fails because the normalized surface and interface areas are 
dominated by the ordered portion of the structure.  The latter approach might be extended to 
handle the more general case of DOT regions, which is a topic for further research. 
Model-based analysis 
Several modeling methods have been applied to, or are applicable to, investigation of 
DOTs from protein structure.  These methods are distinct from comparative and structural 
analysis in that they attempt to predict the physical behavior of proteins, to varying degrees of 
accuracy, based on an initial static structure.  From a practical perspective, they are also 
distinguished by being relatively complex to implement and computationally intensive to apply.   
Molecular dynamics has been applied by several groups in the study of IDPs in general 
and also to the study of DOTs specifically.  In general, molecular dynamics involves simulating 
the atomic motions of a protein in explicit or implicit solvent.  Molecular dynamics has 
successfully been used for discovering intrinsically disordered regions from proteins' structures, 
although relatively long simulations must be performed in order to access the large scale motions 
of IDPs (102, 104).  While powerful and informative, molecular dynamics is difficult to apply on 
a wide scale, both because individual simulations require some fine tuning, and because long 
simulations are computationally intensive.  Also, relatively extensive experience is required in 
order to perform a successful simulation, and so these methods are not generally accessible.  As 
an alternative, less precise but more computationally tractable and more accessible methods have 
been developed for the study of protein flexibility and disorder in protein structures. 
The approach of normal mode analysis has been developed for the study of protein 
flexibility (105).  Both Gaussian network models (107) and elastic network models (108) are 
examples of formalisms for normal mode analysis.  Normal mode analysis evaluates the 
characteristic frequency modes of a protein structure based on the force potentials between atoms, 
where Gaussian networks use realistic potentials and elastic networks use simplified spring 
potentials.  This approach has been used to characterize stabilization induced through crystal 
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packing (95).  Although this method has not been applied to the general study of IDP structures, it 
may be applicable in the sense of intrinsic disorder as an extreme case of flexibility.  However, 
the model's assumption of static non-covalent contacts complicates the interpretation of frequency 
modes in terms of intrinsic disorder, i.e. low frequency intrinsic disorder modes may be trapped 
by transient contacts present in the protein structure. 
Another modeling method developed for the study of protein flexibility is analysis of 
mechanical degrees of freedom, as implemented by the ProFlex algorithm (103).  There are many 
degrees of freedom in the conformation of a protein, which can be represented by backbone Φ 
and Ψ angles and side chain χ angles.  In a folded protein, these degrees of freedom are limited by 
the presence of stable non-covalent contacts between atoms.  The ProFlex algorithm measures 
how much each of a protein's conformational degrees of freedom are limited based on the 
protein's structure.  Over-constrained regions are considered stable and under-constrained regions 
are considered flexible.  Similar to Gaussian network analysis, this method may be applicable to 
IDPs as an extreme case of flexibility.  However, mechanical stability measurement does not 
make allowances for dynamic non-covalent contacts, so interpretation for intrinsically disordered 
regions is not straightforward. 
In contrast to Gaussian network and mechanical stability analyses, a method developed 
for the study of protein flexibility, called the COREX algorithm (101), does not assume static 
non-covalent contacts.  COREX is based on a two-state, i.e. folded and unfolded, model of 
thermodynamic stability.  The algorithm enumerates all the possible states of the protein, where 
each region of the protein can either be folded or unfolded, and calculates the energy of each state 
relative to a reference state, in which every residue is in the folded state.  The probability of a 
residue being unfolded is calculated as the sum of the Boltzmann weights of all states in which 
the residue is unfolded, which is the exponent of the state energy divided by the sum of the 
exponents of the energies of all of the states.  
17 
 
The COREX algorithm has been applied to several proteins with flexibility measured by 
various techniques, e.g. deuterium exchange (109), and shows good agreement with 
experimentally measured flexibilities.  This method is appropriate for studying IDPs, since 
estimating flexibility as an unfolding process describes the DOT process.  The disadvantages of 
this method are its computationally intensive nature and poor scaling properties.  The COREX 
algorithm calculates the surface area of every protein state, and the number of states increases 
exponentially with protein length.  Practically, the algorithm is computationally demanding for 
small proteins, around 180 residues, and quickly becomes intractable for average and long 
proteins.  
Overview 
Chapter II details published (60) work examining the ways in which disorder facilitates 
the regulatory functions of two protein hubs.  This work shows that intrinsic disorder is crucial 
for function of these hub proteins by enabling multiple specificity protein-protein interactions.  
Chapter III is a published (110) examination of the relationship between intrinsic disorder and the 
determination of protein structures by X-ray crystallography (note that Figure 10 and 
accompanying text did not appear in the original publication).  It was found that extensive 
intrinsic disorder can inhibit determination of a proteins structure and that protein crystals have an 
apparently limited tolerance for intrinsically disordered regions.  Chapter IV is a review of 
Molecular Recognition Features (MoRFs) highlighting some of this authors contributions (56, 61, 
99, 111, 112). 
  
18 
 
II. FLEXIBLE NETS: DISORDER AND INDUCED FIT IN THE ASSOCIATIONS OF P53 
AND 14-3-3 WITH THEIR PARTNERS 
Introduction 
Protein-protein interaction (PPI) networks integrate various biological signals including 
those used for energy generation, cell division and growth to give a few notable examples.  The 
architectures of the PPI networks indicate that they are nearly scale free (113–120).  That is, a 
log-log plot of the number of nodes versus the number of links (or interactions) at each node 
gives a straight line with a negative slope.  The negative slope means that these sets of 
interactions contain a few proteins (hubs) with many links and many proteins (non-hubs) with 
only a few links.  The term ‘hub protein’ is relative to the other proteins in a given PPI network, 
with no agreed upon number of links separating hubs and non-hubs. 
Several networks such as the internet, cellular phone systems, social interactions, author 
citations, and so on exhibit scale-free architecture.  With regard to PPIs, scale-free network 
architecture is suggested to provide several biological advantages.  For example, given the small 
fraction of hub proteins, random deleterious mutations will more likely occur in non-hub proteins.  
The elimination of the functions of such non-hub proteins typically have small effects and so, 
generally, are not serious.  In contrast, a deleterious mutation of a hub protein is more likely to be 
lethal (116–121).  Another advantage is that signals can traverse these networks in a small 
number of steps, so signal transduction efficiency is improved compared to that expected for 
random networks (119). 
Understanding PPI network evolution across different species is an important problem 
(122–125).  From this body of work, hub proteins appear to evolve more slowly than non-hub 
proteins, an observation that is consistent with Fisher's classic proposal that pleiotropy constrains 
evolution (126, 127).  Some proteins have multiple, simultaneous interactions (“party hubs”) 
(128) while others have multiple, sequential interactions (“date hubs”) (128).  Date hubs appear to 
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connect biological modules to each other (129) while party hubs evidently form scaffolds that 
assemble functional modules (128). 
The idea that PPI networks use scale-free network topology is receiving considerable 
attention, but some caution is in order.  Currently constructed networks are noisy, with both false 
positive and false negative interactions (120, 130–132).  Also, network coverage to date (133–
136) is not sufficient to prove scale-free architecture (137).  Whether PPI networks are truly 
scale-free or only approximately so, it nevertheless appears to be true that a relatively small 
number of proteins interact with many partners, either as date hubs or party hubs, while many 
proteins interact with just a few partners. 
The ability of a protein to bind to multiple partners was suggested to involve new 
principles (138).  Indeed, neither the lock-and-key (2) nor the original induced-fit (139) readily 
explains how one protein can bind to multiple partners.  Note that the original induced fit 
mechanism was defined as changes in a structured binding site upon binding to the partner (139), 
changes that are analogous to a glove altering its shape to fit a hand.  On the other hand, both 
theoretical and experimental studies over many years suggested that natively unstructured or 
intrinsically disordered proteins form multi-structure ensembles that present different structures 
for binding to different partners (140–146).  Based on these prior studies, we proposed that 
molecular recognition via DOTs provides a mechanism for hub proteins to specifically recognize 
multiple partners (47).  We pointed out earlier that intrinsic disorder could enable one protein to 
associate with multiple partners (one-to-many signaling) and could also enable multiple partners 
to associate with one protein (many-to-one signaling) (146). 
Recent bioinformatics studies support the importance of protein disorder for hubs (147–
151). While disorder appears to be more clearly associated with date hubs (149, 151) than with 
party hubs, some protein complexes clearly use long regions of disorder as a scaffold for 
assembling an interacting group of proteins (152–160).  Thus, the importance of disorder for 
party hubs needs to be examined further.  Additional evidence for the importance of disorder for 
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highly connected hub proteins comes from a structure-based study of the yeast protein interaction 
network (161).  The authors considered only interactions that could be mediated by domains with 
known structures and found that the degree distribution of the resulting network contained no 
proteins with more than 14 interactions, which is more than an order of magnitude less than is 
observed in one unfiltered, high confidence dataset (Jake Chen, personal communication).  This 
result indicates that a structure-based view of hub proteins is insufficient to explain the multitude 
of partners that interact with hub proteins. 
To improve understanding of the use of disorder for binding diversity, we studied two 
prototypical examples: p53 and 14-3-3.  Both are hubs that are clearly involved in crucial 
biological functions.  For example, p53 is a key player in a large signaling network involving the 
expression of genes carrying out such processes as cell cycle progression, apoptosis induction, 
DNA repair, response to cellular stress, etc. (162).  Loss of p53 function, either directly through 
mutation or indirectly through several other mechanisms, is often accompanied by cancerous 
transformation (163).  Cancers with mutations in p53 occur in colon, lung, esophagus, breast, 
liver, brain, reticuloendothelial tissues, and hemopoietic tissues (163).  The p53 protein induces 
or inhibits over 150 genes, including p21, GADD45, MDM2, IGFBP3, and BAX (164). 
The four regions or (not necessarily structured) domains in p53 are the N-terminal 
transcription activation domain, the central DNA binding domain, the C-terminal tetramerization 
domain, and the C-terminal regulatory domain.  The last two could be considered to be a single 
C-terminal domain with two subregions.  The transactivation region interacts with TFIID, TFIIH, 
Mdm2, RPA, CBP/p300 and CSN5/Jab1 among many other proteins (162).  The C-terminal 
domain interacts with GSK3β, PARP-1, TAF1, TRRAP, hGcn5, TAF, 14-3-3, S100B(ββ), and 
many other proteins (162). 
As for 14-3-3 proteins, they contribute to a wide range of crucial regulatory processes 
including signal transduction, apoptosis, cell cycle progression, DNA replication, and cell 
malignant transformation (165).  These activities involve 14-3-3 interactions with various 
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proteins in a phosphorylation-dependent manner.  More than 200 proteins have been shown to 
interact with members of 14-3-3 family (166–168), with these 14-3-3-interacting proteins 
amounting to approximately 0.6% of the human proteome (168).  One proposed functional model 
is that 14-3-3 binds to the specific target as a molecular anvil causing conformational changes in 
the partner.  In their turn, these changes can affect enzymatic (biological) activity of a target 
protein or mask or reveal specific motifs that regulate its localization, activity, phosphorylation 
state, and/or stability (169). 
The 14-3-3 protein has at least nine sequence isomers, called α, β, γ, δ, ε, η, σ, τ, and ζ 
(170).  All isomers are structured dimers with grooves that bind to more than 200 different 
partners, and the different partners have different sequences for their binding regions.  Screening 
experiments have identified individual peptides that bind to all the different isomers, suggesting 
that the binding grooves in the different isomers have some common features (171).  A recent 
bioinformatics study suggests that the partners of 14-3-3 utilize intrinsic disorder for binding 
(172). 
The interactions of p53 and 14-3-3 with their partners as reported previously (170, 173–
188) are examined herein but from an order-disorder point of view.  In the case of p53, different 
regions in the disordered tails enable this protein to bind to multiple partners at the same time.  In 
addition, one single region of disorder adopts clearly different secondary structures and uses the 
same amino acids to different extents in different binding interactions.  For this case the plasticity 
of the disordered region clearly enables the binding to multiple partners.  In the case of 14-3-3, 
the different partners have distinct sequences.  Their interactions with 14-3-3 show 
characteristics, such as hydrogen bonds between side chains of 14-3-3 and the backbone of the 
partners and such as hydrogen bonds between the backbone of the partners and water, indicating 
that the two partners were very likely unfolded in water just prior to association with 14-3-3.  The 
distinct sequences of the partners do not adopt identical backbone structures, and the various side 
chain interactions between 14-3-3 and the two different partners involve induced-fit adjustments 
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of the 14-3-3 structure.  Overall, these studies show how the plasticity of disordered proteins is 
used to enable the binding diversity of hub proteins, both for a single disordered region binding to 
multiple partners and for multiple disordered regions binding to the same partner. 
Results 
Intrinsic disorder and the molecular interactions of p53 
The p53 molecule interacts with many other proteins in order to carry out its signal 
transduction function.  A number of these are downstream targets, such as transcription factors, 
and others are activators or inhibitors of p53's transactivation function.  Many of these 
interactions have been mapped to regions of the p53 sequence (Figure 1, gray boxes): the N-
terminal domain (i.e., the transactivation domain), the C-terminal domain (i.e., the regulatory 
domain), and the DNA binding domain (DBD).  These domains have also been characterized in 
terms of their structure or lack thereof (Figure 1, red (disordered) and blue (structured) segments), 
where the DNA binding domain is intrinsically structured and the terminal domains are 
intrinsically disordered (189, 190).  While the tetramerization domain is structured (191), the 
structure is acquired upon the formation of the complex.  Additionally, multiple different 
posttranslational modifications have been identified in p53 (Figure 1, vertical ticks).  These 
modifications are relevant here because they are a common method for altering protein 
interactions. 
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Figure 1.  Summary of p53 interactions and structure.  Dark gray boxes indicate the approximate 
binding regions of p53's known binding partners.  The regions of p53 represented in structure 
complexes in PDB are represented by horizontal bars, labeled with the name of the binding 
partner.  For the DBD, the extent of the globular domain is indicated by the light gray box, where 
the internal horizontal bars indicate regions involved in binding to a particular partner.  Post 
translational modifications sites are represented by vertical ticks.  Experimentally characterized 
regions of disorder (red) and order (blue) are indicated by the horizontal bar.  Finally, predictions 
of disorder (scores > 0.5) and order (scores < 0.5) are shown for two PONDR predictors: VLXT 
(solid line) and VSL2P (dashed line).  All features are presented to scale, as indicated by the 
horizontal axis.  The p53 interaction partners and post translational modification sites have been 
adapted from Anderson & Appella (162). 
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Comparing the regions of order and disorder reveals a strong bias towards the 
localization of the interactions within the intrinsically disordered regions.  Overall, 60/84 = 71% 
of the interactions are mediated by intrinsically disordered regions in p53.  A bias toward 
intrinsically disordered regions is even more pronounced in the sites of posttranslational 
modifications, with 86%, 90%, and 100% of observed acetylation, phosphorylation, and protein 
conjugation sites, respectively, found in the disordered regions.  This is consistent with previous 
observation of a strong bias for post translational modifications toward intrinsically disordered 
regions (62).  This concentration of functional elements within intrinsically disordered regions 
compares to just 29% of the residues being disordered (47).  Clearly, p53 exhibits a highly biased 
use of disordered regions for mediating and modulating interactions with other proteins. 
In addition to experimentally characterized disorder, predictions of intrinsic disorder for 
p53 using both PONDR VL-XT (8) and VSL2 predictions (192) were carried out (Figure 1, 
graph).  The latter is one of the highest accuracy prediction algorithms available (193), whereas 
the former has been observed to be especially useful in identifying binding regions within longer 
regions of disorder (111, 194, 195) and to be much better at identifying such sites as compared to 
a number of different disorder predictors (196).  Both predictors give good agreement with the 
experimental determination of intrinsic disorder (7, 13, 44, 45, 62, 197–211), and in the case of 
p53 both of their predictions agree well with experimental characterization. 
Analysis of associations involving p53 using 3D structures 
The structures of 14 complexes between various regions of p53 and unique binding partners have 
been determined (Figure 1, horizontal bars).  For 10 of these partners, the interactions are 
mediated by regions experimentally characterized as intrinsically disordered, where PONDR VL-
XT detects the majority of these binding regions as short predictions of order within a longer 
prediction of disorder.  These structures are complexes between p53 and endogenous partners: 
cyclin A (173), sirtuin (174), CBP (175), S100ββ (176), set9 (177), tGcn5 (178), Rpa70 (179), 
MDM2 (180), Tfb1 (181), and itself (182).  The remaining four interactions are mediated by the 
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structured DBD, namely between p53 and three endogenous partners – DNA (183), 53BP1 (184), 
and 53BP2 (185) – and one exogenous partner – the large-T antigen (LTag) from simian virus 40 
(188). 
Protein complexes can be formed from the association of structured proteins by the 
folding of one disordered protein onto the surface of a structured partner or by the coupled 
folding and binding of intrinsically disordered proteins (100, 212–218).  Nussinov and 
collaborators (100) showed that a plot of normalized monomer area (NMA) versus normalized 
interface area (NIA) nicely separates complexes formed from structured proteins as compared to 
complexes formed from unfolded proteins by coupled binding and folding. That is, associations 
of structured proteins exhibit small NMAs and NIAs and so lie near the origin of the NMA-NIA 
plot.  Conversely, complexes formed by coupled binding and folding have much larger NMAs 
and NIAs and so are spread out and lie far from the origin of the NMA versus NIA plot.  Indeed, 
a linear boundary separates the two groups (100).  It should be emphasized that the NMA-NIA 
plot approach is a global measure of a protein's order-disorder monomeric state and has not been 
characterized on local order-disorder transitions (e.g. disordered binding loops in an otherwise 
well-ordered protein). 
As described in more detail in the implementation, by developing two separate NMA-
NIA plots, one for each partner of a complex (Figure 2A), and then by determining the distance to 
the linear boundary in each plot, a double NMA-NIA plot (Figure 2B) can be produced.  
Interacting pairs can be divided into the three groups given above, namely: (1) both partners are 
structured (region (i) of Figure 2B), i.e. both distances are negative; (2) one partner is structured 
and the second partner is disordered, i.e. the ordered partner has a negative distance and the 
disordered partner has a positive distance (regions (ii+ and ii-) of Figure 2B); and (3) both 
partners are intrinsically disordered, i.e. both distances are positive (region (iii) of Figure 2B).  
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Figure 2.  Double NMA-NIA plot for p53 complexes.  (A) The definition of boundary distance 
used in the double NMA-NIA plot, where ordered structures have a negative boundary distance 
and disordered structures have a positive boundary distance.  (B) The double NMA-NIA plot for 
the p53 structures shown in Figure 1, with the exception of DNA-bound p53. 
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A double NMA-NIA plot was calculated for 13 of the p53 complex structures (Figure 
2B).  The p53-DNA complex was excluded since the NMA-NIA analysis is not relevant for 
nucleic acids.  In the general case, the distinction between the distances of the two partners is 
arbitrary, so that the double NMA-NIA plot is symmetric about the diagonal.  However, here we 
restrict the p53 distance to one axis, so that group (2) is split into two sub groups (regions (ii+ and 
ii-)): the p53 segment is disordered and the partner is ordered (region (ii-)), and the p53 region is 
ordered and the partner is disordered (region (ii+)).  One interaction, the formation of the p53 
tetramer, is in the third group (region (iii)) and so therefore likely involves an association between 
two disordered partners.  This is consistent with experimental data (189).  At the opposite side of 
the spectrum, the three protein-protein complexes involving the p53 DBD domain are in group 1 
(region (iii)), indicating that all three are ordered prior to binding, which is consistent with the 
solution of structures for identical or homologous monomeric domains (e.g. p53 DBD (219), 
53BP1 BRCT domain (220), 53BP2 SH3 domain (221), and LTag (188)).  The other nine p53 
complexes found so far in the PDB are all in the group 2 quadrant (that is, in region (ii-), and so 
all likely involve a disordered region of p53 associating with a structured partner.  These results 
are likewise consistent with experimental data.  That is, these p53 regions are disordered in the 
unbound state (189, 190), and the isolated partners appear to be structured: MDM2 (222), Rpa70 
(179), Tfb1 (181), tGCN5 (223), Cyclin A/CDK2 (224), sirtuin (225), CBP (226), S100ββ (227), 
and set9 (228)). 
In summary, these data point out the importance of DOTs for many of the structurally 
characterized interactions involving the p53 hub protein.  While many previous studies discuss 
these same interactions, to our knowledge the importance of disorder has not been emphasized in 
those previous studies. 
Analysis of multiple specificities in the p53 C-terminus 
So far, complexes involving one region of the p53 sequence bound to four different 
partners have been determined and deposited in the PDB.  This region is from residue 374 to 388 
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in the p53 sequence bound to one of the following: cyclin A (173), sirtuin (174), CBP (175), or 
S100ββ (176).  The regions that mediate these interactions and their respective secondary 
structures were mapped precisely to the p53 sequence (Figure 3A).  Although slightly different 
residues of the p53 sequence are used in each interaction, there is a very high degree of overlap, 
with a span of 7 core residues being the same (Figure 3A).  Interestingly, the four complexes 
display all three major secondary structure types.  The core span becomes a helix when binding to 
S100ββ, a sheet when binding to sirtuin, and a coil with two distinct backbone trajectories when 
binding to CBP and cyclin A2 (Figure 3A). 
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Figure 3.  Sequence and structure comparison for the four overlapping complexes in the C-
terminus of p53.  (A) Primary, secondary, and quaternary structure of p53 complexes.  (B) The 
ΔASA for rigid association between the components of complexes for each residue in the relevant 
sequence region of p53.  The two hatched bars indicate acetylated lysine residues. 
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Because the secondary structures are distinct, it seems likely that p53 utilizes different 
residues for the interactions with these four different partners.  To examine this, the buried 
surface area for each residue in each interaction was quantified by calculating the ΔASA (Figure 
3B).  Different amino acid interaction profiles are seen for each of the interactions, showing that 
the same residues are used to different extents in the four interfaces.  The particularly large ΔASA 
peaks for K382 in complexes with CBP and sirtiun (indicated by the hatched bar) are due to extra 
buried areas arising from the acetylation of this residue.  This highlights the importance of 
posttranslational modification for altering PPI networks. 
Analysis of multiple specificities of the p53 DBD 
The p53 molecule contains another set of overlapping interactions that contrasts with 
those at the C-terminus.  These interactions are mediated by the DNA binding domain and 
include interactions with DNA (183), the BRCT domain of 53BP1 (184), the SH3 domain of 
53BP2 (185), and the large T-antigen (LTag) of Simian Virus 40 (188).  Here we compare these 
four interactions using the methods described in Figure 4. 
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Figure 4.  p53 DBD interaction with different binding partners.  The interaction profiles (A) and 
rendered structures (B) for the four unique complexes of the p53 DBD.  Rendered structures 
depict p53 as a ribbon and each interaction partner as a molecular surface.  The interaction 
profile-structure pairs are (from top to bottom): p53-DNA, p53-53BP1, p53-53BP2, and p53-
sv40. 
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The structures of the p53-DNA, the p53-53BP1, the p53-53BP2, and the p53-LTag 
complexes are shown (Figure 4B).  While all of the ligands are different, they all bind to basically 
the same region of p53. 
Comparison of the interface profiles of the four complexes (Figure 4A) shows a large 
difference in the pattern of interface residues used by p53.  For instance, there are several residues 
at the N-terminal end of the DBD which are only found in interaction with DNA.  Similarly, 
interface residues near the C-terminal end participate in binding to different extents in three 
interactions but not at all in the p53-53BP1 interaction.  The differing usage of residues in each 
interaction is the most prevalent feature of this data.  However, there are also several residues 
contributing an exceptionally large amount of surface area in each complex (e.g., M243 and 
R248). 
While the focus of this paper is on the roles of disorder in the interactions involving two 
different hub proteins, the DNA binding domain of p53 presents the opportunity to study 
structural changes involving one structured region binding to several different structured partners.  
For this purpose, we compiled a 4-panel set of plots for characterizing the induced fit as one 
protein binds to different partners (Figure 5).  These panels show the average interface area 
(Figure 5A), the standard deviation of the interface area (Figure 5B), the differences in side chain 
conformation (Figure 5C), and differences in backbone conformation (Figure 5D).  Furthermore, 
regions that are highly exposed to solvent are also indicated (Figure 5, blue shading), so that 
structural differences due to interactions can be distinguished from those due from intrinsic 
flexibility – disordered loops – or crystallization artifacts. 
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Figure 5.  Comparison of residue interactions with structural differences for bound p53 DBD.  
The average (A) and standard deviations (B) were calculated over the four interaction profiles of 
the p53 DBD shown in Figure 4.  These are shown aligned with the side chain RMSF (C) and the 
backbone RMSF (D) calculated from the four structures of bound p53 DBD.  Regions of residues 
that are highly exposed to solvent in all complex structures are indicated by the blue-shaded 
regions. 
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These induced-fit profiles exhibit a number of interesting features (Figure 5).  The most 
striking of these is the region from residue 240 to residue 250.  This region shows a large and 
variable interaction interface, which is associated with large side chain and backbone 
conformational differences.  This is true also of a smaller region around residue 120.  Other 
interaction regions show only side chain conformational differences associated with variable 
interface areas.  Other conformational differences observed are limited regions of high solvent 
exposure, which suggests that these changes are due the details of the crystallization conditions 
more than interaction with a particular binding partner. 
Together, these results suggest that multiple partners of p53 are accommodated by 
reusing similar binding interfaces.  This is facilitated by small scale or large scale structural 
differences, which range from differences in side chain conformation to backbone 
rearrangements.  It should be noted that this differs from our finding in a more limited analysis on 
only the p53-53BP1 and -53BP complexes (229). 
Analysis of the multiple specificities of 14-3-3 
Five different 3-D structures of the 14-3-3ζ protein bound to distinct partners were found in PDB.  
These partners include a peptide from the tail of histone H3 (230), serotonin N-acetyltransferase 
(AANAT) (186), a phage display-derived peptide (R18) (187), and motif 1 and 2 peptides (m1 
and m2, respectively) (170).  For AANAT, only the region within the canonical 14-3-3 binding 
site is included in our analysis with the globular region being deleted.  Two additional structures 
were not included because they were either unsuitable for structural analysis or were highly 
redundant with another structure.  All peptides are phosphorylated in their respective structures 
except R18, which contains a glutamate in place of the phosphoserine. 
The five bound peptides' sequences were aligned structurally as described in the methods. 
Likewise, the 14-3-3 domain structures were independently aligned, without considering the 
bound peptides.  Next the 14-3-3 alignment was anchored manually by the observed 
correspondence of the bound peptide Cα atoms at the 0 and -1 positions and by extending the 
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alignment without gaps from the anchor positions, thereby giving the final structural alignment 
(Figure 6A).  In terms of sequence, the R18 sequence has no identical positions to any other 
peptide.  The number of identities between the other peptides range from 1 to 4. 
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Figure 6.  Sequence and structure for five peptides bound to 14-3-3ζ.  (A) Sequence alignment of 
the bound peptides and the RMSF of their conformations.  Solid gray bars give the RMSF for 
four peptides – excluding R18 – and the hatched bars give the RMSF for all five peptides.  (B) 
Aligned ribbon representations of the structures of the five peptides, which were aligned through 
multiple alignment of their respectively bound 14-3-3 domains, shown along with a 
representative ribbon representation of a 14-3-3 domain. 
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There is high overlap in the backbone trajectories of the 5 peptides from position -3 to 1 
but large divergences at either end of the structural alignment (Figure 6A).  This divergence at the 
ends is apparent qualitatively in the superimposed structures of the five peptides (Figure 6B).  
Structural divergence and sequence variability are loosely correlated, where positions with three 
identical residues have a lower divergence than those with no identical residues.  This suggests 
that 14-3-3 may use different binding pocket residues to interact with different peptide residues.  
The R18 sequence, which is divergent from the others, makes a large contribution to the 
estimated RMSF values (indicated by the cross-hatched bars, Figure 6A). 
The factors contributing to the ability of 14-3-3 to bind to distinct peptides were 
estimated by a detailed structural analysis.  The peptide binding residues of 14-3-3 are located 
primarily in a central cleft, made up of four helices (Figure 7A), which has been noted previously 
by several researchers.  The standard deviation of ΔASA for the peptide binding residues (Figure 
7B) show that the residues with the most binding variability are located at either end of the 
central cleft, which is consistent with the variation of peptide backbone trajectories in these 
regions.  Backbone variability in bound 14-3-3 structures (Figure 7C) is restricted to the ends of 
most of the binding cleft helices.  These observations suggest that large a conformational change 
in 14-3-3 is not necessary for multiple specificities, although some small adjustments at the ends 
of binding helices may be necessary. 
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Figure 7.  Peptide binding residues of 14-3-3ζ.  (A) The Cβ atoms of all residues involved in 
binding in any of the five peptide bound structures are shown (red) along with the rest of the 
backbone (light blue ribbon).  (B) The standard deviation in the area bound on complex formation 
is displayed by coloring the Cβ atoms of peptide binding residues on a gradient, from a standard 
deviation of 0Å2 (blue) to 10Å2 and greater (red).  (C) The backbone RMSF of the 14-3-3 domain 
calculated over Cα atoms displayed as a color and radius gradient, from an RMSF of 0Å (blue, 
0.25Å) to an RMSF of 2.0Å and greater (red, 2.0Å).  (D) The side chain RMSF is displayed by 
coloring the Cβ atoms of peptide binding residues on a gradient, from a RMSF of 0Å (blue) to an 
RMSF of 0.50Å and greater (red).  All parameters were calculated using all five of the peptide-
14-3-3 complexes. 
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To assess the role of side chain conformational changes in peptide binding, the RMSF of 
side chain atoms was calculated (Figure 7D).  The side chain RMSF and standard deviation of 
ΔASAs give similar indications for many binding site residues, where residues used 
inconsistently across multiple complexes are the most likely to undergo conformational 
rearrangement.  These are the same residues that are located at the broadest parts of the binding 
site.  However, a few residues deep in the binding grove show both consistent participation in the 
binding interface and variable side chain conformation.  These observations suggest that the 
primary, high level mechanisms of 14-3-3 multiple specificity are a broad binding site that allows 
multiple trajectories (and therefore interaction with different residues) and side chain 
rearrangement to accommodate different peptide sequences. 
To further analyze the conformational changes in 14-3-3 upon binding to its multiple 
partners, we show the 4-panel induced-fit profile described above (Figure 8).  Contrary to the 
results seen for the p53 DBD, 14-3-3 is much more static in its multiple interactions.  All regions 
displaying large conformational differences across bound complexes are also highly exposed to 
solvent and play no direct role in mediating binding to any peptide.  The plots do show several 
small scale structural differences – side chain rearrangements – associated with variable 
participation in peptide binding, particularly in the regions 40-60 and 215-230. 
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Figure 8.  Comparison of residue interactions with structural differences for bound 14-3-3ζ.  The 
average (A) and standard deviations (B) were calculated over the five 14-3-3ζ-peptide interaction 
profiles.  These are shown aligned with the side chain RMSF (C) and the backbone RMSF (D) 
calculated from the five structures of bound 14-3-3ζ.  Regions of residues that are highly exposed 
to solvent in all complex structures are indicated by the blue-shaded regions.  
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14-3-3 binding to two different partners 
To gain further insight into 14-3-3 binding to different partners, we compared a pair of 14-3-3 
binding peptides in detail.  These two peptides, m1 and m2, were derived from two motifs, 
identified through the screening of peptide libraries for sequences that bound to all 14-3-3 
isoforms (171).  These two peptide structures have been compared previously (170), but here we 
reanalyze these structural data from the order-disorder point of view. 
As noted previously (170), the backbone traces of the two peptides are noticeably 
different even though the m1 and m2 peptides bind to essentially the same region of 14-3-3ζ 
(Figure 9A and B, respectively).  Examining the side chain interactions of these peptides with 
specific 14-3-3 residues (Figure 9C and D) shows that there is difference in the location and 
identity of the residues involved, which is consistent with the aggregate findings (Figure 7 and 
Figure 8).  Similarly, distinctive hydrogen bonding patterns are exhibited between the two 
peptides and 14-3-3ζ and between the two peptides and bound water (Figure 9C and D).  Since a 
cardinal feature of a structured protein is internal satisfaction of hydrogen bond donors and 
acceptors, these data are both consistent with the peptides being from unstructured regions of 
protein before binding. 
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Figure 9.  Detailed analysis of 14-3-3ζ peptide binding.  The m1 peptide (A, orange ribbon) and 
m2 peptide (B, red ribbon) bound to 14-3-3 (A and B, shown by the green and blue surface, 
respectively).  Details of 14-3-3 peptide binding are shown by a chemical schematic for the m1 
peptide (C) and the m2 peptide (D), where both crystallographic waters (blue) and implicit waters 
(red) are shown.  (E) Superposition of the backbone atoms from the 4 helices with the primary 
peptide binding residues for m1 (green) and m2 (blue) bound 14-3-3.  (F) Superposition of 
ribbons of the same 4 helices showing the side chains of the residues that participate in m1 
(green) and/or m2 (blue) binding. 
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The above data on the complexes suggest that 14-3-3ζ has distinct conformations when 
bound to the two different peptides.  Overlaying the backbone structures of the four binding 
helices from both complexes – based on a pair-wise alignment of the complete domains – shows 
only minor variability in conformation, with the most occurring at the helix spanning residues 
216 to 228 (Figure 9E).  Finally, comparison of side chain conformation in the two complexes 
shows significant differences in several of 14-3-3ζ side chains (Figure 9F, residues outlined in red 
show significant movement) and several other minor differences.  Overall, these data suggest that 
a difference in the conformations of some side chains with rather less difference in backbone 
conformations is sufficient to accommodate the binding of two different phosphopeptides by the 
14-3-3ζ molecule. 
Discussion 
Use of disordered regions for binding 
The large majority of the binding sites on the p53 sequence map to the disordered regions of this 
protein (Figure 1), indicating that intrinsic disorder commonly provides the binding sites for the 
various partners that associate with p53.  Recent bioinformatics investigations suggest that the 
majority use of disorder for binding to multiple partners is quite likely to be a general result (147–
151). 
The p53 binding sites are often indicated on the order-disorder predictions as dips, in 
other words as short segments with structure tendency flanked by regions of disorder tendency on 
both sides.  Starting from this observation, we previously developed a predictor of such regions, 
which we called molecular recognition features, or MoRFs, because such regions “morph” from 
disorder to order upon binding (111, 194).  Others have used the PONDR VL-XT order/disorder 
plots or MoRF predictors to identify potential binding sites that were subsequently verified by 
laboratory experiments (195, 231).  For some of these predicted examples, the regions did indeed 
form helices upon binding to their partners (232, 233).  By greatly enlarging the training set, we 
recently improved the MoRF predictor.  Interestingly, when tested against several order-disorder 
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predictors including ones from other laboratories, PONDR VL-XT gave the clearest indication of 
binding sites within disordered regions (196). 
Others developed a sequence-based approach to identify short, conserved recognition 
sites, called eukaryotic linear motifs (ELMs) (234–236).  While MoRFs are identified by general 
order/disorder tendencies and while ELMs are identified by motif discovery from sequence 
analysis, the resulting binding sites identified by both methods share several features (237).  The 
use of different residues in the same disordered fragment for one-to-many signaling leads to a 
potential problem with the ELM model.  That is, the concept behind ELMs is that each ELM uses 
a common set of amino acids for binding to different partners.  These common amino acids 
therefore show up as an over-represented pattern leading to a “linear motif”.  What if a region 
used to bind to multiple partners uses different secondary structures and different amino acids?  
In such a case, the residues in the “linear motif” would not necessarily be over-represented.  It 
will be interesting over time to determine whether ELMs having stronger signals use a reduced 
set of structures for their interactions. 
While the observed binding sites in the disordered regions of p53 have a localized 
tendency for ordered structure, not all disorder-associated binding sites exhibit such features.  We 
have found many binding sites that are associated with high disorder prediction values across the 
entire spans of the binding sites, one example of which was recently published (238).  Many of 
these dipless MoRFs form irregular structures upon binding with their partners, and often such 
binding regions are rich in proline.  Our recent study of the complexes that form when various 
disordered segments bind to ordered partners indicates that the disorder-associated binding 
regions have distinct sequence features, even when the bound structure is irregular or sheet 
instead of helix, and so it should be feasible to develop a specific predictor for each of the 
different types of MoRFs (56). 
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One-to-many signaling 
Date hubs bind to different proteins at different times.  Figure 3 shows how a single region of p53 
binds to four different partners.  The amino acids involved in each interaction show a significant 
overlap, and no two of these interactions could exist simultaneously.  Furthermore, the same 
residues adopt helix, sheet, and two different irregular structures when associated with the 
different partners.  Finally, the same amino acids are buried to very different extents in each of 
the molecular associations.  These results show very clearly how one segment of disordered 
protein can bind to multiple partners via the ability to adopt distinct conformations. 
The idea that one segment of protein can adopt different secondary structures depending 
on the context is not new.  Many unrelated proteins have identical subsequences of length six, and 
sometimes even up to length eight, with the same sequences often adopting different secondary 
structures in different contexts (239–241).  Such sequences have been called chameleons for their 
ability to adopt different structures in different environments (240–246).  Chameleon behavior 
could be an important feature that enables one disordered region to bind to multiple partners.  
With different secondary structures and with different side chain participation in the different 
complexes, it is as if one sequence can be “read” in multiple ways by the various binding 
partners. 
Chameleon behavior occurs for short peptides (octamers), for longer protein fragments, 
and even for entire proteins.  For example, the 17 residues-long arginine-rich RNA binding 
domain (residues 65–81) of the Jembrana disease virus (JDV) Tat protein recognizes two 
different transactivating response element (TAR) RNA sites, from human and bovine 
immunodeficiency viruses (HIV and BIV, respectively). The JDV segment adopts different 
conformations in the two RNA contexts and uses different amino acids for recognition (243).  In 
addition to the above conformational differences, the JDV domain requires the cyclin T1 protein 
for high-affinity binding to HIV TAR but not to BIV TAR (243).  Another protein with 
chameleon properties is human α-synuclein, which is implicated in Parkinson's disease and in a 
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number of other neurodegenerative disorders known as synucleinopathies.  This protein may 
remain substantially unfolded, or it may adopt an amyloidogenic partially folded structure, or it 
may fold into α-helical or β-strand species, including both monomeric and oligomeric species.  In 
addition, this protein can form several morphologically different types of aggregates, including 
oligomers (spheres or doughnuts), amorphous aggregates, and amyloid-like fibrils (145). 
Such chameleon sequences likely underlie the multiple specificity binding sites common 
in p53.  For a quick calculation of the implied degree of interface overlap, assume that each 
residue in a region has equal probability to interact with a partner and consider the C-terminus of 
p53.  The disordered C-terminus (~100 residues) associates with at least 44 distinct partners.  The 
average length of a binding site in this region is ~14 residues, which means that on average only 
100/14=7 partners bind at any given residue in the C-terminus.  This simple back-of-the-envelope 
calculation suggests that multiple specificity sequences may be the rule for p53 interactions, 
rather than a curiosity of a single region.  However, available data suggest that interactions do not 
overlap in a random fashion, but rather interactions are localized to specific regions.  For 
example, consider that the majority of the structures available for the C-terminus of p53 involved 
the same region of sequence.  Therefore, the back-of-the-envelope calculation provides an 
approximate minimum degree of overlap, where the actual degree of overlap is likely much 
higher.  This idea, which is an extension of a previous proposal (100), further suggests a general 
mechanism by which hub proteins could bind to such a large multitude of partners, which cannot 
be explained from the viewpoint of interaction between two structured proteins (161). 
Finally, the p53 DBD offers a counter example to the disorder-based view of date hubs.  
That is, it uses the same or similar face of its globular structure to bind to multiple partners.  
While the p53 DBD is a folded protein, it does exhibit some remarkable structural differences 
when bound to different partners.  It seems unlikely that these local regions of the p53 DBD 
structure are well folded in isolation, otherwise the association rate of some or all of these 
complexes would be relatively low.  This idea is supported by the finding that the p53 DBD is 
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only marginally stable at physiological temperature (247).  Therefore, it is plausible that these 
regions of the monomeric DBD are only transiently folded in solution, where crystallization 
conditions cause a shift toward the folded state in monomeric crystal structures.  The double NIA-
NMA plot data (Figure 2B) does not contradict this idea, since it is limited to global analysis and 
this idea only applies to local regions of the DBD.  This idea is conjecture and further 
experimental or simulation evidence is needed to test this idea.  In any event, however, the p53 
DBD demonstrates that even in proteins generally thought to be well folded, structural changes 
can still occur in association with multiple specificity. 
Many-to-one signaling 
In 14-3-3, a common binding groove in a structured dimeric protein can be fitted by multiple, 
distinct sequences provided by many different binding partners.  A recent bioinformatics study 
(172) found that14-3-3 proteins, and the 14-3-3 binding regions in particular, are predicted to be 
highly disordered by multiple disorder prediction methods.  The authors proposed that 14-3-3 
recognition generally involved coupled binding and folding of the recognition region.  Our results 
support this conclusion because the backbone of m1 and m2 peptides are highly hydrated in the 
bound state (Figure 9C and D), indicating that the binding peptide is likely to be unstructured 
prior to binding (62). 
One idea is that 14-3-3 holds its bound partner in a non-active state (172).  Even though 
14-3-3 likely binds to disordered regions in its partners (data herein and (172)), this idea of 
blocking the active structure could still be true.  For example, the productive state of 14-3-3's 
partner might involve the binding of the partner to a second partner via the same disordered 
region that binds to 14-3-3, in which case 14-3-3 binding would prevent the formation of the 
productive complex.  Another possibility is that the disordered region exhibits an equilibrium 
between a bound state that activates the protein and an unbound state that inactivates the protein.  
The association of the unbound disordered region with 14-3-3 would then hold 14-3-3's partner in 
the non-productive state as proposed previously. 
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We previously suggested that disordered segments with different sequences could use 
their flexibility to bind to a common binding site, thereby facilitating many-to-one signaling 
(146).  The multiple recognition of 14-3-3 depends on this mechanism to a considerable degree, 
with the different peptides taking different paths through the binding cleft and interacting with 
binding site residues in distinct ways (Figure 6B). 
In addition, structured proteins also have a degree of flexibility, and so the binding site 
backbone and side chain residues can undergo shifts (induced-fit mechanisms) to help 
accommodate interactions with distinct sequences (Figure 6 and Figure 8).  Thus, induced-fit 
mechanisms are important for structured protein interactions with different partners whether the 
partners are structured or intrinsically disordered. 
The induced-fit mechanisms observed for 14-3-3 and the DNA binding domain of p53 
are commonly observed in other situations.  For example, tethering, in which a peptide is 
covalently linked to its protein target to allow detection of low affinity interactions, often results 
large-scale side chain movements concomitant with peptide binding (248).  Also, when many 
different MoRFs and their binding partners are examined, induced-fit movements in the 
structured partners are very commonly observed (56).  Similarly, small backbone shifts and side 
chain conformational changes are both important for 14-3-3's ability to bind multiple partners. 
For all of these examples, the associations involve coupled binding and folding for the disordered 
peptide partner coupled with a near universal classical induced fit for the structured side of the 
partnership. 
One-to-many signaling vs. many-to-one signaling 
The p53 C-terminus and 14-3-3 use intrinsic disorder differently with regard to enabling 
multiple binding specificities.  In p53, drastic conformational changes enable distinct surfaces to 
be exposed to binding partners.  In 14-3-3, subtle differences in 14-3-3 conformation and peptide 
binding locations enable multiple specificities.  Why would nature use one mechanism rather than 
the other for a particular biological role?  The interactions of p53 serve to activate or inhibit its 
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primary role as a transcription regulator, while 14-3-3 alters the functions or subcellular 
localization of many proteins.  From this, one can make some highly speculative proposals: (1) 
disorder binding regions play a passive role in regulation by providing a specific binding site – 
i.e. the disordered regions are the identification sites of the protein to be regulated (9) – and (2) 
ordered proteins play the active role – i.e. altering the activity of the proteins they bind to – where 
recognition of disordered regions allows for a generalized specificity so that a single protein can 
alter the activity of many others.  Validation of the accuracy and generality of these ideas requires 
further study. 
Conclusion 
Here we have examined the mechanisms of multiple specificities in two date hub-like 
hub proteins.  Evidence here and elsewhere (147–151) suggests that disordered regions may be an 
extremely common mechanism by which hub proteins bind to their multitude of partners.  The 
specific examples of p53 and 14-3-3 contrast the mechanisms by which disorder facilitates 
multiple recognition.  Two regions of p53 are highlighted: the C-terminus, which is intrinsically 
disordered, and the central DNA binding domain, which is structured.  The C-terminus binds four 
different partners with the same residues, forming distinct structures and using distinct residues in 
their respective complexes.  The structural heterogeneity of the bound complexes highlights the 
importance of intrinsic disordered in the unbound state.  The DNA binding domain also binds to 
four different partners, where these complexes use some distinct residues and some common 
residues.  Residues that participate in multiple complexes show small to large scale structural 
rearrangements, which indicate either induced fit and/or structural instability in these regions.  
Both the C-terminal and DBD examples demonstrate how proteins can accommodate multiple 
partners through distinct conformations.  A contrasting example is provided by 14-3-3, which 
binds to multiple partners without large scale conformational changes.  14-3-3 accommodates 
multiple partners with distinct sequences via broad binding surfaces surrounding the common 
charge clamp.  Individual partners take different path over the binding surface with 
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accompanying changes in side chain conformation.  The variably in conformations of bound 
partners highlights how disordered fascilitates multiple recognition of 14-3-3.    
These examples suggest two distinct models of disorder mediated multiple recognition: 
one-to-many, where one disordered region recognizes multiple partners though assuming distinct 
conformations; and many-to-one, where many disordered regions recognize a single binding site 
on a structured partner.   Work subsequent to that presented here has found dozens of more 
examples of one-to-many (61) and many-to-one (Hsu et al., manuscript in preparation) binding in 
PDB.  For one-to-many binding, examples mirror binding observed for p53 C-terminus, where 
the region adopts unique conformations to accommodate different partners.  For many-to-one 
binding, binding sites showed widely varying amounts of overlap on the binding surface, which is 
consistent with the findings for 14-3-3.  This work indicates that these binding models may be 
common in nature.   
A next step in this research is to distinguish single target disordered regions from one-to-
many binding.  Specifically, several methods for predicting disordered regions have been 
developed (see Chapter IV), and could be extended for this purpose.  One possible avenue for 
extension is examination of relative conservation of single target and one-to-many disordered 
binding regions.  The hypothesis is that sequences of one-to-many binding regions will be more 
highly constrained between species than single target binding regions.  That is, residues in one-to-
many regions will be more resistant to mutation due to their participation in multiple interfaces, 
versus single target regions that can undergo correlated mutation with their partners without 
effecting other interactions.  Distinguishing single target and one-to-many regions is useful 
generally to find the relative prevalence of these regions, and also to help determine possible 
functions of novel binding regions. 
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Methods 
PONDRs VL-XT and VSL1 
Predictions of intrinsic disorder in HPV proteins were performed using a set of PONDR 
(Predictor Of Natural Disordered Regions) predictors, VL-XT and VSL2.  PONDR VL-XT 
integrates three feed forward neural networks: the Variously characterized Long, version 1 (VL1) 
predictor from Romero et al. 2001 (8), which predicts non-terminal residues, and the X-ray 
characterized N- and C- terminal predictors (XT) from Li et al. 1999 (249), which predicts 
terminal residues.  Output for the VL1 predictor starts and ends 11 amino acids from the termini.  
The XT predictor's output provides predictions up to 14 amino acids from their respective ends.  
A simple average is taken for the overlapping predictions; and a sliding window of 9 amino acids 
is used to smooth the prediction values along the length of the sequence.  Unsmoothed prediction 
values from the XT predictors are used for the first and last four sequence positions. 
The recently developed Various Short-Long, version 1 (PONDR-VSL1) algorithm is an 
ensemble of logistic regression models that predict per-residue order-disorder (192, 250).  Two 
models predict either long (>30 residues) or short (<15 residues) disordered regions based on 
features similar to those used by VL-XT.  The algorithm calculates a weighted average of these 
predictions, where the weights are determined by a meta-predictor that approximates the 
likelihood of a long disordered region within its 61-residue window.  Predictor inputs include 
PSI-blast profiles (251), and PHD (252), and PSI-pred (253) secondary structure predictions. 
Structure surface and complex interface analysis 
Solvent accessible surface area (ASA) was calculated from atomic protein structure 
numerically using the double cubic lattice method (254) as implemented in the Biochemical 
Algorithms Library (255).  Using this algorithm, ASA of residues and entire chains can be 
calculated. 
To determine interface areas, for example between two chains, the ASA of each 
individual chain is calculated, as well as the ASA of the complex.  The interface area is then 
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calculated as the change in ASA (ΔASA), i.e. the sum of the individual chain ASA minus the 
complex ASA.  Residues directly involved in interactions were identified from molecular 
structures as residues with a ΔASA greater than 1 Å2 (214, 215).  All calculations used a probe 
radius of 1.4 Å, which roughly corresponds to the size of a water molecule. 
Order-disorder evaluation from known structure 
The work of Gunasekaran et al. has previously shown that, in many cases, the order-
disorder state of a protein prior to complex formation is reflected in the complex structure (100). 
Specifically, a plot of the normalized monomer area (NMA) – ASA divided by the number of 
monomer residues – versus the normalized interface area (NIA) – ΔASA divided by the number 
of monomer residues – effectively distinguishes between ordered and disordered monomers using 
a linear boundary.  This effectiveness of this NMA-NIA plot has been validated on an expanded 
dataset and an optimal linear boundary has been estimated and evaluated. The equation for the 
novel boundary is: 
<NMA> = 157.43 – 3.51 <NIA> 
Since the NMA-NIA plot can only represent one partner of a complex, the double NMA-
NIA plot was developed to simultaneously represent both monomers of a binary complex – or 
complexes that can be treated as binary, such as two monomers bound to a dimer.  Rather than 
plotting the NMA and NIA directly, the Euclidean distance to the order-disorder boundary is 
calculated, where disordered monomers have a positive distance and ordered monomers have a 
negative distance.  Then the boundary distances of each monomer in a binary complex can be 
plotted against each other to give an overall order-disorder prediction for the complex.  
Other structure calculations 
The root mean squared fluctuation (RMSF) is a commonly used measure of variability 
across multiple structure alignments.  Here, RMSF of the protein backbone is approximated as the 
RMSF of the Cα atoms.  The equation used is 
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where 𝐶𝛼𝑗,𝑖 is the position vector of the ith Cα atom of the jth complex and 𝐶𝛼𝚤���� is the averaged 
position for the ith amino acid from the multiple sequence alignment of N structures.  The 
program MultiProt (256) was used to generate the multiple sequence alignments for RMSF 
calculation and structure rendering. 
To estimate side chain conformation variability among multiple protein structures, the 
RMSF of side chain residues was calculated.  In this calculation, the residue atoms Cα,Cβ, 
backbone carbonyl carbon, and backbone nitrogen were used to align a residue to a selected 
reference residue of the same type.  Thus aligned, the RMSF was calculated over side chain 
carbons beyond the Cβ.  Consequently, no side chain RMSF was calculated for Glycine or 
Alanine residues.  The RMSF was also corrected for the number of atoms in the side chain 
beyond the Cβ. 
The solvent accessibility of individual residues was calculated relative to an extended 
Gly-X-Gly model peptide (257), which gives a conservative estimate of relative solvent exposure, 
i.e. underestimates relative solvent exposure.  Residues exposed to solvent were defined as those 
with an accessible surface area at least 40% of that of the reference area for that residue type.  
This cutoff is arbitrary, but cutoffs for solvent exposed residues as low as 20% have been used by 
others, e.g. (258).  Solvent exposures were calculated in the context of binary complexes, which 
is valid for p53 complexes.  In 14-3-3 complexes, 14-3-3 forms homotypic dimmers in addition to 
binding to phosphopeptides, so residues found to be highly solvent exposed are either actually 
exposed to solvent or involved in the homodimer interface.   
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III. UTILIZATION OF PROTEIN INTRINSIC DISORDER KNOWLEDGE IN STRUCTURAL 
PROTEOMICS 
Introduction 
Structure determination, historically, has been attempted on a protein-by-protein basis, 
typically after an accumulation of years or decades of study on each particular protein.  
Information regarding solubility, stability, pH range, and temperature sensitivity was therefore 
generally well known.  Consequently, due to lack of suitable samples, structure determination 
was not usually attempted on proteins that were ill behaved in solution.  The Protein Structure 
Initiative (PSI) or Structural Genomics Initiative (SGI) (259–262) has turned the status quo on its 
head by attempting to determine structures without prior knowledge of a protein's behavior and to 
do this rapidly on a large scale.  Despite the obvious success of the PSI Centers in decreasing the 
overall cost of determining novel structures (263), ill-behaved proteins continue to represent 
major challenges that hamper the efficiency of structure determination.  One source of ill-behaved 
proteins is intrinsic protein disorder. 
Prediction techniques and data mining have shown that intrinsically disordered proteins 
(IDPs) and proteins with regions of intrinsic disorder are likely to be quite common (7, 8, 10, 49, 
264–266).  Disordered proteins or regions are defined herein as entire proteins or regions of 
proteins that lack a fixed tertiary structure.  A given region of intrinsic disorder might be ordered 
or disordered, depending on the physiological or experimental conditions.  For instance, a protein 
may undergo a DOT upon binding to a cofactor, DNA, or protein partner.  On the other hand, 
proteins that lose rigid structure in the presence of denaturants are not considered to be disordered 
proteins.  Similarly, proteins that fold into specific 3-D structure only under condition of extreme 
molecular crowding are not considered ordered.  IDPs and intrinsically disordered regions are 
noticeably different from structured globular proteins and their domains at several levels, 
including amino acid composition, sequence complexity, hydrophobicity, charge, and flexibility.  
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Many of these differences were used in the development of several disorder predictors (reviewed 
(41, 267–271)). 
Disordered protein can impact many of the processes in the structure determination 
pipeline, including expression and stability (272, 273), solubility (201, 274), and crystallization 
(12, 13, 201, 275–277).  Therefore, it is advantageous to filter highly disordered proteins from the 
target list.  Also, many structured proteins contain isolated regions of intrinsic disorder, which 
can inhibit crystallization.  Fragments remaining after removal of disordered regions may 
crystallize when the whole protein did not (201), and so a method for identification of disordered 
regions to allow for intelligent target improvement would be of great utility. 
Here we examine the impact of intrinsic disorder on the various stages of the structure 
determination pipeline and outline several applications of Predictors of Natural Disordered 
Regions (PONDRs) that can improve the efficiency of structure determination efforts.  To 
evaluate the tolerance of intrinsic disorder in protein crystals, missing density in the Protein Data 
Bank (PDB) was evaluated in light of the various sources of missing density in addition to 
intrinsic disorder.  This analysis indicates that extensive disorder in PDB is relatively rare and 
highlights the benefit of filtering crystallization targets for intrinsic disorder.  Several disorder-
based target prioritization criteria are evaluated and retrospectively applied to protein targets in 
the TargetTrack database, the progress tracking module of the PSI Structural Genomics 
Knowledgebase.  This evaluation suggests that disorder prediction provides an effective means 
for prioritizing targets for structure determination pipelines.  Finally, the use of disorder 
prediction for tailoring proteins for structure determination is examined. 
Materials and Methods 
Protein datasets 
For analysis of missing density, protein structures without nucleic acid from the July 
2012 version of PDB (278) were used in conjunction with the S2C database 
(http://dunbrack.fccc.edu/Guoli/s2c/index.php).  The latter provides alignments between residues 
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with defined density and the reported sequence (SEQRES), greatly simplifying identification of 
apparent missing density.  The number of residues and proportion of apparent missing density 
were calculated with respect to the contents of the asymmetric unit.  Several structures were 
excluded from the list of cases of extreme missing density due to idiosyncratic issues with these 
structures: 1EFM because a large portion of defined density was not fit by the author (279), 
1YD7 because no supporting reference was available and neither solvent content nor Mathew's 
coefficient was reported, and 3JQH and 4HB1 because these structures contain chains with exact 
repeats and the asymmetric unit contains less than one copy of the chain in the asymmetric unit.  
Three idealized sets of proteins were assembled for these studies.  The “ordered proteins” set 
consists of the entire sequences of all the X-ray crystallography-determined structures from PDB 
Select 25 proteins (280).  This set contains 929 proteins with 230,205 residues.  The “disordered 
proteins” set consists of proteins compiled from literature searches where the known disordered 
regions comprise ≥ 80% of the entire sequences.  This set contains 48 proteins with 9,219 
residues.  The “X-ray proteins with disorder” set consists of crystallized proteins with disordered 
regions ≥ 30 residues.  This set contains 53 proteins with 17,191 residues. 
We also analyzed all the proteins currently available at the PSI Structural Biology 
Knowledgebase (http://sbkb.org), namely at its target progress tracking module (TargetTrack: 
http://sbkb.org/tt/), which provides status and tracking information on the production protein 
targets and their structure solution (281).  Targets' sequence and status were taken from the XML 
distribution of the database, as of July 2012.  Status tags for each trial were normalized by adding 
tags from previous pipeline steps that were missing.  For targets with multiple trials, the trial 
showing the furthest pipeline progression was selected as representative of the target.  From 
302,311 selected targets deposited by worldwide Contributing Centers in to TargetTrack, 201,825 
were cloned, of which 120,802 were expressed.  Of the expressed proteins, 51,303 were purified, 
of which 8,168 were crystallized, of which 5,125 produced diffraction-quality crystals.  So far, 
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according to the July 2012 TargetTrack, 4,203 crystal and 1,600 NMR structures have been 
solved. 
Intrinsic disorder prediction 
PONDR algorithms predict per-residue, two-state order/disorder from amino acid 
sequence (40, 249, 282).  Although several PONDRs have been developed to date (8, 40, 193, 
249, 250, 282–286), only one of these predictors, VL-XT, is used here.  This choice of this 
predictor was made because PONDR VL-XT is one of the best characterized members of the set 
of PONDR predictors. 
PONDR predictions are real numbers between 0 and 1, where values of 0.5 or more are 
predictions of disorder.  Raw PONDR prediction output is commonly plotted, as distribution of 
disorder scores over the protein sequence.  An alternative representation is to map predictions to a 
bar, where black represents a region predicted to be disordered and white represents a region 
predicted to be ordered.  Predictions can also be quantified per-protein, using measures such as 
percent of residues predicted to be disordered or the longest predicted disordered region.  These 
measures are particularly useful because of the dependency of false positive rates on the length of 
the disorder prediction. 
PONDR VL-XT was constructed from a neural network trained on disordered proteins 
collected from the literature.  The VL-XT predictor integrates three feed-forward neural network 
predictors: the various long predictor version 1.0 (VL1) (284), the N-terminus predictor (XN), 
and the C-terminus predictor (XC) (249), and achieves good accuracy both on held-out training 
set sequences and on out-of-sample sequences (8).  Prediction of VL-XT on O_PDB_S25 (8), 
which is a set of defined density regions from sequence unique structures from PDB, gave an 
accuracy of 80%.  Prediction on the disordered data gave an accuracy of 60%, suggesting that 
VL-XT does not generalize well for prediction of disorder (8). 
PONDR is available on the web at http://www.pondr.com.  The web interface does not 
support batch predictions.  Arrangements for large numbers of predictions can be made by 
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contacting the corresponding authors.  It is important to note that although there are many 
predictors of protein intrinsic disorder (41, 267–271), we anticipate that similar results would be 
found with other predictors. 
Model fitting 
To evaluate combinations of disorder prediction based criteria, logistic regression models 
were fit using proteins that reached a given status in the structure determination pipeline as a 
positive set and remaining proteins as a negative set.  The purpose of fitting these models was not 
to create binary predictors of status progression, but rather to determine an appropriate linear 
combination of parameters.  The statistics package R (http://www.r-project.org/) was used to fit 
models, using the standard generalized linear model function to fit models and the package 
ROCR (287) to calculate the area under the curve (AUC) measure of predictor performance.  The 
AUC was selected to compare models because it emphasizes the separation of the positive and 
negative dataset, where 1.0 is prefect separation and 0.5 is completely interspersed, and is 
independent of any kind of prediction threshold. 
Results and Discussion 
Missing density and intrinsic disorder in the PDB 
To evaluate the tolerance of crystal structures for intrinsic disorder, we examined the -
extent of missing density in existing crystal structures.  Although missing density regions have 
often been equated to intrinsic disorder, apparent missing density in crystal structures may arise 
from several sources, including disordered regions, mobile domains, and proteolysis.  Disordered 
regions may be present in the crystal but fail to diffract X-rays due to heterogeneous or dynamic 
structure.  For multi-domain proteins, mobile domains may be present; a domain may have a 
heterogeneous or dynamic orientation and position in the crystal, resulting in missing density in 
the solved crystal structure.  Although not intrinsically disordered themselves, the mobility of 
domains may be facilitated by intrinsically disordered linkers.  Finally, rational or fortuitous 
proteolysis may occur prior to or during crystallization, but these altered sequences are often not 
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reflected in the PDB record.  While several authors have noted that removal of intrinsically 
disordered regions can facilitate crystallization and diffraction, e.g. Ref. (201), the use of 
proteolysis is not consistently reported and the integrity of crystallized chains not routinely 
verified. 
The most extreme cases of apparent missing density in terms of longest region of missing 
density and largest fraction of residues in missing density regions were collected from PDB 
(Table 1).  All of these structures have over half of their residues in apparent missing density 
regions or at least one apparent missing density region longer than 200 residues.  Much of the 
missing density found was due to the anticipated sources, (likely) proteolysis, (likely) mobile 
domains and intrinsic disorder, but much apparent missing density was due to misannotation.  
Misannotations are less frequent than other sources of missing density and are limited to cases 
where only a portion of a sequence was included in experiments, but a longer sequence was 
reported in the PDB record, e.g. PDB ID: 4ACO.  For the purposes of this study, apparent 
missing density due to misannotations is functionally equivalent to proteolysis.  Discounting 
misannotation and proteolysis, and PDB record limitations, missing density regions attributable to 
residues physically present in protein crystals are limited to about 50% of residues when mobile 
domains (around 40% of residues for confirmed cases of mobile domains) are present and about 
30% of residues for intrinsically disordered regions.   
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 Table 1.  Extreme cases of missing density in the PDB.  The most extreme cases of apparent 
missing density in the PDB in terms of the longest missing density region (LMDR) and the 
fraction of residues in missing density regions (FMDR). 
Structure Residues LMDR FMDR 
Reason for extreme  
missing density Reference 
1M1J 2744 273 0.28 Disordered  (288) 
1SCF 1092 122 0.59 Misannotation (289)  
1SRQ 1364 208 0.25 Mobile domain (290)  
2HQX 492 116 0.63 Likely proteolysis  (291)  
2HZ7 851 220 0.35 Mobile domain  (292)  
2IG2 671 217 0.32 Likely mobile domain1  
2J4W 883 378 0.47 Likely mobile domain  (293) 
2J5L 1019 446 0.54 Likely mobile domain  (293) 
2JCH 720 217 0.36 Proteolysis (294, 295) 
2JE5 1440 222 0.36 Proteolysis  (295) 
2JKU 94 36 0.63 Proteolysis  (296) 
2VF4/2VF5 608 242 0.41 Mobile domain  (297) 
2WZL 303 196 0.65 Proteolysis  (298) 
3BJC 878 537 0.65 Misannotation  (299) 
3DUF/3DVA/ 
3DV0 
3632 263 0.22 Misannotation  (300) 
3EVY 478 147 0.65 Proteolysis2  
3FG7 796 277 0.73 Proteolysis  (301) 
3GHG 5768 362 0.33 Proteolysis and Disordered  (302) 
3JZY 510 385 0.76 Proteolysis2  
3KIC/3KIE 14720 216 0.29 Likely disordered1  (303) 
3L7L/3L7M/ 
3L7J/3L7I 
2916 313 0.44 Misannotation  (304) 
3NG9 7360 216 0.29 Likely disordered1  
3ORE 988 220 0.25 Likely mobile domain  (305) 
3R05/3QCW 2048 230 0.23 Likely mobile domain  (306) 
4ACO 956 419 0.53 Misannotation  (307) 
4AQ1 2044 264 0.22 Likely mobile domain  (308) 
1 Classification based in part on disorder prediction 
2 Based on authors note in the PDB record 
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To illustrate the implications of a large amount of intrinsic disorder on a protein crystal, 
the crystal lattice of the protein with the longest disordered region – fibrinogen (Figure 10, upper 
panel) – was rendered and compared to that of a well ordered protein – myoglobin (Figure 10, 
lower panel).  The crystal packing for fibrinogen clearly displays large gaps relative to the tight 
crystal packing of myoglobin.  However, the reported solvent content of each of these structures 
is comparable, 65.3% and 64.4% for fibrinogen and myoglobin, respectively.  This implies that 
the large gaps in the crystal lattice are packed with relatively compact intrinsically disordered 
residues.  One possible explanation for the high tolerance for intrinsic disorder in fibrinogen 
crystals is that the elongated structure of fibrinogen allows for a lattice with more gaps that would 
not be tolerated by packing of a globular protein. 
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Figure 10.  Examples of the crystal packing.  Packing of the unit cells of two different crystal 
structures are shown: fibrinogen (1M1J) and myoglobin (1MDN).  The surfaces of each copy of 
the asymmetric unit are rendered in different colors and truncated by the faces of the unit cell. 
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In addition to extreme cases of missing density in PDB, missing density across crystal 
structures in PDB was evaluated (Figure 11).  To account for the presence of mobile domains, we 
applied disorder prediction to the sequences of all PDB chains and filtered missing density 
regions by the fraction of residues predicted to be disordered.  However, we were unable to 
account for proteolysis or misannotation in this analysis, so these results should be considered an 
upper bound; there is less missing density due to residues physically present in the protein crystal 
than indicated by these results.  The cumulative fraction of missing density regions by length 
(Figure 11A) shows that missing density regions are often short, with between 85% and 95% of 
regions being 20 residues long or shorter depending on the predicted disorder cutoff.  Also, 
missing density regions with a moderate fraction of predicted disorder (0.3) tend to be longer than 
all missing density regions and regions with a larger proportion of predicted disorder, which 
suggests that many of these intermediately disordered regions may include mobile domains.  The 
cumulative fraction of structures by length of its longest missing density region (Figure 11B) 
shows that between 23% and 47% of structures have no missing density residues and that the vast 
majority of structures, between 85% and 95%, contain no missing density regions longer than 20 
residues. 
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Figure 11.  Cumulative histograms of missing density in the PDB.  Cumulative histograms of (A) 
missing density regions by length and (B) structures by length of the longest missing density 
region in any protein chain in the structure. For each, missing density regions were filtered by the 
fraction of residues predicted to be disordered: no filtering (threshold of 0.0), at least partially 
disordered (threshold of 0.3), mostly disordered (threshold of 0.7), and completely disordered 
(threshold of 1.0). 
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The overall picture of missing density in the PDB provided by this analysis is that 
missing density is infrequent in PDB structures, and when present tends to be limited to relatively 
short regions.  When long regions of disorder are present in the crystal (Table 1, structures 1M1J, 
3KIC, and 3NG9) the total proportion of disordered residues in the structure is below 30%.  
Disorder prediction suggests that much of the missing density in PDB does arise from 
intrinsically disordered regions, while some arises from mobile domains and an unknown amount 
from proteolysis and misannotation.  The limited amount of intrinsic disorder present as missing 
density regions agrees with the idea that intrinsically disordered regions, particularly long 
disordered regions, inhibit successful determination of crystal structures, and it suggests that 
avoiding or tailoring disordered proteins may aid in the determination of crystal structures. 
Target prioritization with disorder prediction 
Per-protein assessments of disorder by PONDR can contribute to a target prioritization 
scheme in a straightforward manner.  For example, a cut-off value for a given quantity establishes 
a filter, while weights determined from the given measure provide a means for prioritization.  
Using different scoring schemes, specific cut-off values are suggested below, but it is suggested 
that alternative values be considered for each particular application in order to balance the rates of 
false prediction of disorder with tolerable disorder content.  Likewise, the relative weights 
calculated from the different disorder schemes could be used to prioritize the selected targets with 
the proteins having less predicted disorder receiving the higher ranks. 
The genome-wide measures of predicted disorder will be effective in prioritization, 
provided proper attention is paid to the balance between false prediction of disorder and false 
prediction of order.  As illustrated in Table 2, the rate of false prediction of disorder drops 
drastically with increasing number of contiguous predictions of disorder.  However, there is a 
corresponding increase in false prediction of order.  There is no clear indication of the extent of 
this increase, due to the limited number of proteins in the current disorder protein dataset and 
uncertainty in the boundaries of disordered regions.  Prediction sensitivity will be most directly 
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affected by limiting the minimum size of disordered regions that prediction will detect.  Because 
many procedures in molecular biology, including protein crystallization, can be relatively 
insensitive to small regions of disorder, ignoring contiguous disorder predictions of modest length 
(e.g., less than 40 residues) should not adversely affect the practical use of PONDR predictions.  
The thresholds for any of the weighting schemes presented should be selected, in reference to 
Table 2, so that the overall rate of false prediction of disorder is in balance with the desired 
preference for the sensitivity of the predictions.  Finally, it should be noted that the rate of false 
prediction of disorder may be somewhat overestimated in Table 2.  The O_PDB_S25 contains 
chains from complex structures, which may contain DOT regions involved in binding (7) that are 
correctly predicted to be disordered. 
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Table 2.  PONDR VL-XT error rates as a function of number of consecutive prediction of 
disorder.  Pre-residue error rates are calculated as the number of amino acids in predicted 
disordered region of the given length or longer, divided by the number of residues in the set of 
ordered proteins.  Per-protein error rates are calculated as the number of proteins containing at 
least one predicted disordered region of the indicated length or longer, divided by the number of 
proteins in the set of ordered proteins.  These calculations were made using only residues with 
defined coordinates from the “ordered proteins” set. 
 
Minimum Number of 
Consecutive Predictions of 
Disorder 
Per-Residue 
Error Rate 
Per-Protein 
Error Rate 
1 20% 98% 
10 15% 82% 
20 8% 46% 
30 4% 29% 
40 2% 8% 
50 0.5% 2% 
60 0.1% 0.5% 
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Target prioritization using percent predicted protein disorder 
Shown in Figure 12A are the cumulative histograms for the ordered, disordered, and X-
ray with disorder datasets as a function of the percent of total sequence predicted to be 
disordered.  This measure gives good separation between the sets of structured proteins and 
disordered proteins and could serve to indicate proteins that are mostly disordered.  The weakness 
of this approach is that, while proteins that are highly disordered can be filtered, mostly ordered 
sequences containing enough disorder to hinder high throughput protocols may be overlooked by 
this measure.  However, if longer proteins receive a lower priority, a simple percent of residues 
predicted to be disordered cutoff may be useful without additional criteria. 
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Figure 12.  Cumulative histograms of predicted disorder in the ordered, disordered, and X-ray 
with disorder datasets.  Disorder is summarized for each protein in the set by three different 
methods: (A) the percentage of residues per-protein predicted to be disordered, (B) the longest 
consecutive disorder prediction, and (C) the number of residues within predicted regions of 
disorder of 20 residues or longer.  The dotted and dashed lines in each plot represent aggressive 
and conservative cutoffs, respectively, and are discussed in the text. 
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The percent of proteins with proportions of predicted disorder less than that indicated on 
the X-axis rises much more sharply for the ordered proteins and the X-ray proteins with disorder 
sets than the disordered protein set (see Figure 12A) .  Although such a relationship is expected 
for an order-disorder predictor of reasonable accuracy, the position of the X-ray disorder set is 
particularly important.  A large fraction of proteins in many genomes likely contain relatively 
long regions of disorder (10, 49, 264, 265), and such proteins should be removed from the 
structure determination target list.  However, the presence of relatively short regions of disorder 
does not imply that a protein would not be amenable to structure determination.  Since a high 
proportion of X-ray disorder proteins have relatively low predicted disorder content, a 
prioritization scheme using the percent of residues predicted to be disordered would be useful. 
Two example cut-off values are indicated in the cumulative histograms of Figure 12A.  
The dotted lines in the figure illustrate an aggressive filtering and weighting scheme using 30% or 
less of residues predicted to be disordered as the cutoff.  Based on these example datasets, this 
would eliminate 90% of the disordered proteins while retaining 75% of the ordered proteins and 
55% of the crystallizable proteins having disordered regions.  A more conservative cutoff is 
illustrated with the dashed lines in Figure 12A.  Using this threshold of 60% or less of each 
sequence predicted to be disordered, nearly all of the ordered proteins and the X-ray disordered 
proteins (98% and 96%, respectively) can be retained while eliminating over half (56%) of the 
disordered proteins. 
Target prioritization using total predicted protein disorder 
For larger proteins, a small percentage of predicted disorder could correspond to a large 
amount of total disorder, which could inhibit the structure determination process.  Two alternative 
measures of total predicted disorder are suggested as possibilities to overcome this problem (see 
Figure 12B and C).  Proteins removed from a target list by these two measures could be separated 
into their ordered regions and their disordered regions for further study. 
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The two suggested measures of total predicted disorder are analyzed in Figure 12B and 
C.  The first measure, Figure 12B, considers the longest disorder prediction in each protein, 
where the length is given by the x-axis value.  The second measure, Figure 12C, presents the 
number of residues in predicted regions of disorder of 20 residues or longer in each protein, 
where the number of residues is given by the x-axis value. 
The longest predicted disordered region could be used for prioritization by eliminating 
proteins with predicted disordered regions of 40 residues or longer.  Such an aggressive scheme 
would retain 91% of ordered proteins and 68% of X-ray disorder proteins as targets, and 
eliminate 58% of disordered proteins from consideration, as indicated by the dotted line in Figure 
12B.  A longest predicted disordered region cutoff of 70 residues, represented by the dashed line 
in the same figure, represents a more conservative filtering scheme.  This would retain 99% of 
ordered proteins and 89% of X-ray disordered proteins but eliminate only 29% of completely 
disordered proteins. 
Alternatively, the total number of residues in predicted disordered regions of 20 or longer 
could be used as a prioritization attribute, with a cutoff of 40 residues as indicated by the dashed 
line in Figure 12C.  Approximately 62% of disordered proteins could be filtered while retaining 
78% of ordered proteins and 59% of X-ray disorder proteins.  With a conservative threshold of 80 
residues, 94% of ordered proteins and 76% of X-ray disorder proteins are retained while 44% of 
the disordered proteins would be eliminated. 
Retrospective evaluation of predicted disorder based filtering 
The effectiveness of the proposed methods of disorder-based filtering for crystallization 
targets was examined through a retrospective evaluation.  For this, disorder predictions were 
made and evaluated for all proteins in the TargetTrack database.  Since the use of disorder-based 
filtering in selected proteins would confound retrospective evaluation, we examined the 
TargetTrack database for biases in the content of predicted disorder.  Based on the idea that 
targets were not filtered for disorder in the initial years of the PSI, targets were grouped by the 
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year they were first selected and the values of the filtering criteria were compared.  As can be 
seen by the plot of mean percent predicted disorder by year (Figure 13), targets selected in early 
years of the project have significantly more disorder than those selected in the latter years of the 
project.  Note that the high proportion of predicted disordered in targets selected in 2004 and 
prior relative to those selected in 2007 and later is not reflected in analogous plots for total 
disorder (Figure 14 and Figure 15).  The latter plots show no pattern in the bias of disorder 
content based on the selection year of targets.  These results suggest that disorder prediction has 
been used for target filtering by contributing centers using a criterion similar to percent predicted 
disorder.  Based on this result, targets selected in 2004 or before were taken as a set of unfiltered 
structure targets, and targets selected in 2007 and before were taken as a set of filtered targets. 
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Figure 13.  Predicted disorder in the TargetTrack database by year.  Means of the percentage of 
predicted disorder for targets in the TargetTrack database.  Targets are grouped by the year 
targets were first selected. Error bars give the 95% confidence interval of the mean. 
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Figure 14.  Means of the longest disordered region of targets in the TargetTrack database.  
Targets are grouped by the year targets were first selected.  Error bars give the 95% confidence 
interval of the mean. 
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Figure 15.  Means of the number of residues within predicted regions of disorder of 20 residues or 
longer of targets in the TargetTrack database.  Targets are grouped by the year targets were first 
selected.  Error bars give the 95% confidence interval of the mean. 
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Disorder prediction based filtering was evaluated by CDF plots for unfiltered targets 
using the proportion predicted disorder (Figure 16A), number of residues in disordered regions of 
20 residues or longer (Figure 16B), and longest disordered region (Figure 17) criteria.  These 
plots have one curve for each target status in the crystal structure pipeline, which progresses in 
the following order: selection, cloning, expression, purification, crystallization, diffraction, and 
structure determination.  Each criterion shows a progressive loss of disordered proteins in 
subsequent steps of the structure determination pipeline.  Also, the curves for targets with 
determined structures (black line in Figure 16A, B, and Figure 17) closely follow the curves for 
ordered proteins (empty line in Figure 12A, B, and C), which indicates that ordered proteins are 
an appropriate model for successful structure targets.  Comparison of the curves for selected 
targets with curves for targets with determined structures suggests that disorder based filtering 
provides an effective method for increasing pipeline efficiency; depending on criteria and 
threshold selection, 5% to 20% of selected proteins could be filtered at the suggested thresholds 
while losing relatively few successful structure targets. 
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Figure 16.  Cumulative histograms for targets in the TargetTrack database for (A and C) 
percentage of predicted disorder and (B and D) number of residues within predicted regions of 
disorder of 20 residues or longer.  Plots for two selection date thresholds are shown: (A and B) 
2004 or earlier and (C and D) 2007 or later. 
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Figure 17.  Cumulative histogram for the longest consecutive disorder prediction for targets in the 
TargetTrack database with selection dates in 2004 or earlier. 
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The impact of disorder based filtering was also investigated by examining filtering 
criteria for the set of filtered targets, i.e. those targets selected in 2007 and later.  As expected, the 
plots of proportion of predicted disorder (Figure 16C) show little to distinguish selected targets 
from successful structure targets.  Therefore, little efficiency could be gained from further filters 
based on this criterion.  However, both total disorder criteria, number of residues in LDRs (Figure 
16D) and longest disordered region (Figure 18), show a large difference in predicted disorder 
between selected and successful structure targets, although this difference is somewhat reduced 
compared to unfiltered targets (Figure 16 and Figure 18, respectfully).  This suggests that not 
only is a low proportion of intrinsic disorder important for successful structure determination, but 
also that there is a limit to the absolute number of disordered residues a well-diffracting crystal 
can tolerate.  Therefore, further gains in pipeline efficiency could possibly be gained by the use of 
multiple criteria. 
Combinations of disorder criteria were examined by fitting logistic regression models and 
evaluating these models with the AUC performance measure.  Single parameter models were also 
evaluated for comparison.  These models were fit on proteins selected in 2004 and prior from the 
TargetTrack database, using proteins yielding crystal structures as one class and all other proteins 
as the other class.  The goal in fitting these models was not to develop binary predictors of 
whether or not a protein will yield a crystal structure, but rather to determine an appropriate linear 
combination of parameters.  AUC is used as a measure of separation between the two classes, 
which is appropriate since AUC is independent of threshold and the logistic function transform. 
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Figure 18.  Cumulative histogram for the longest consecutive disorder prediction for targets in the 
TargetTrack database with selection dates in 2007 or later. 
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Comparison of AUCs for combinations of parameters (Table 3) shows that addition of 
parameters improves separation performance.  Combination of all three disorder prediction 
parameters provides the best performance.  However, all three parameters is only marginally 
better than the next best combination, fraction of disordered residues (FDR) and number of 
residues in long disordered regions (NDR), and the latter is examined further.  The cumulative 
histogram of the linear combination of FDR and NDR is shown in Figure 19.  Note that the linear 
combination is 0.0092 NDR–0.72 FDR, where the signs indicate that NDR has a negative impact 
on crystallization but that FDR has a positive impact on crystallization.  The apparent positive 
influence of FDR on pipeline progress, which contradicts the current working hypothesis, was 
investigated further by fitting FDR-NDR logistic regression models for each combination of 
subsequent target status tags (Table 4).  The positive relationship between FDR and structure 
pipeline progression persists except for progression of purified targets, for which both FDR and 
NDR are detrimental. 
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Table 3.  Logistic regression classification performance for combinations of disorder prediction-
based parameters, longest predicted disordered region (LDR), number of residues in predicted 
disordered regions longer than 20 residues, and fraction of residues predicted to be disordered, 
measured by the area under the curve (AUC). 
 
Disorder Parameter 
AUC LDR NDR FDR 
+ - - 0.578 ± 0.020 
- + - 0.584 ± 0.013 
- - + 0.533 ± 0.023 
+ + - 0.583 ± 0.020 
+ - + 0.589 ± 0.017 
- + + 0.595 ± 0.020 
+ + + 0.600 ± 0.020 
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Figure 19.  Cumulative histogram for targets in the TargetTrack database selected in 2004 or 
earlier by the linear combination of percentage of predicted disorder and number of residues 
within predicted regions of disorder of 20 residues or longer (equation given in text).  
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Table 4.  Performance and parameter ranges of logistic regression models from cross validation 
for targets selected in 2004 or earlier.  Positive (negative) parameter values indicate that greater 
(lesser) values inhibit (enhance) progression from the start status to the end status. 
Status Tags 
AUC 
Parameter Range 
Start End FDR NDR 
selected cloned 0.547 [0.595, 0.684] [0.00060, 0.00082] 
selected expressed 0.543 [-0.245, -0.171] [0.00182, 0.00202] 
selected purified 0.597 [-1.180, -1.114] [0.00834, 0.00900] 
selected crystallized 0.573 [-0.319, -0.248] [0.00592, 0.00638] 
selected diffraction 0.583 [-0.513, -0.328] [0.00695, 0.00828] 
selected crystal structure 0.594 [-0.887, -0.627] [0.00843, 0.00954] 
cloned expressed 0.551 [-0.769, -0.622] [0.00167, 0.00203] 
cloned purified 0.599 [-1.508, -1.434] [0.00848, 0.00878] 
cloned crystallized 0.562 [-0.566, -0.312] [0.00514, 0.00648] 
cloned diffraction 0.573 [-0.618, -0.493] [0.00643, 0.00739] 
cloned crystal structure 0.588 [-0.995, -0.766] [0.00826, 0.00915] 
expressed purified 0.595 [-1.231, -1.108] [0.00809, 0.00860] 
expressed crystallized 0.544 [-0.073, 0.219] [0.00403, 0.00459] 
expressed diffraction 0.556 [-0.194, 0.030] [0.00520, 0.00603] 
expressed crystal structure 0.572 [-0.488, -0.291] [0.00642, 0.00752] 
purified crystallized 0.519 [0.673, 1.073] [-0.00174, -0.00078] 
purified diffraction 0.521 [0.663, 0.907] [-0.00029, 0.00022] 
purified crystal structure 0.520 [0.344, 0.502] [0.00112, 0.00210] 
crystallized diffraction 0.531 [-0.333, 0.049] [0.00276, 0.00408] 
crystallized crystal structure 0.565 [-1.113, -0.775] [0.00495, 0.00656] 
diffraction crystal structure 0.559 [-1.949, -0.741] [0.00538, 0.00642] 
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The relationship between predicted disorder and structure pipeline progression suggested 
by these results is 3-fold: (1) NDR generally inhibits pipeline progression, while (2) FDR (in 
conjunction with NDR) benefits pipeline progression from expression through purification but (3) 
FDR (in conjunction with NDR) inhibits pipeline progression from purification through to 
crystallization.  Relationship (2) is somewhat contrary to the current working hypothesis, but can 
be reconciled in the following way.  Successful protein purification is dependent on protein 
solubility, so the current observation is consistent with recent results that show that intrinsic 
disorder can greatly increase protein solubility (309).  Relationships (1) and (3) agree with 
expectation since disorder has been observed to complicate each step in the structure 
determination process, from expression to solubility to crystallization. 
Expression levels can suffer from the reduced stability of intrinsically disordered 
proteins, due to their inherent proteolytic sensitivity; intrinsically disordered proteins are digested 
much faster than ordered proteins (24, 310–313).  Solubility of some proteins with disordered 
regions can be very low under conditions promoting the native state.  For example, the 
aggregation of wild type Bcl-2 was remedied by replacing its disordered region of Bcl-2 with a 
portion of the disordered region of Bcl-xL, reducing aggregation and allowing structure 
determination of the chimera (274).  Crystallization is unlikely for completely disordered proteins 
or proteins with too much intrinsic disorder because of their flexible and very dynamic nature.  
Myelin basic protein (MBP) exemplifies these troublemakers (314).  One exhaustive series of 
attempts to crystallize MBP for X-ray diffraction has been reported, where the authors tried 4,600 
different crystallization conditions but were unable to induce crystallization of MBP (275).  
Based on these observations the myelin basic protein has been suggested to belong to the 
category on “uncrystallizable” proteins.  It can be safely assumed that many other unsuccessful 
crystallization attempts for numerous other proteins have not been reported, since negative results 
are generally assumed to be unsuitable for publication.  In the case of MBP, several additional 
studies suggest that this protein lacks fixed 3D structure, existing instead as in intrinsically 
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disordered ensemble, which in turn have been suggested to provide the basis for its 
multifunctionality (315). 
Target improvement with disorder prediction 
Many protein structures in PDB are fragments of full-length gene products.  These 
structures often represent independently folding domains and are invaluable for understanding the 
biological functions of these proteins.  Ordered regions need to be identified and isolated, 
preferably without the use of extensive (and costly) experimentation.  This section illustrates 
some ways in which expert analysis of PONDR predictions can provide a starting point for the 
isolation of ordered regions and disordered regions from their larger host proteins. 
Disordered termini detection 
Many proteins contain long regions of disorder at either the amino or carboxyl terminus 
or at both termini.  Removing these terminal disordered regions can often improve protein 
handling and crystallizability.  Crystallization trials for three proteins, NEIL1 (201), RluC, and β-
recombinase, exemplify such a target improvement scheme.  The original crystallization attempts 
for these proteins began with the full-length sequences. 
NEIL1, a human homolog of Escherichia coli DNA glycosylase endonuclease VIII, 
represents an illustration of the non-trivial correlation between disorder, solubility, and 
crystallizability.  Crystallization trials for full-length C-terminally His-tagged NEIL1 failed to 
yield any crystals.  This inability to grow crystals was corroborated by the fact that the protein 
was polydisperse based on the dynamic light-scattering analysis, and this polydisperse feature 
persisted regardless of the temperature or buffer conditions used (201).  To overcome this 
obstacle, PONDR VL-XT was used to detect disordered region(s) in NEIL1 that may hinder 
crystallization.  This analysis predicted that the protein has a disordered C-terminal region (201).  
Based on this observation, a construct missing the entire disordered C-terminal region (last 106 
amino acids) in NEIL1 was designed.  Little or no soluble protein expression was observed with 
this construct.  A series of shorter C-terminal deletion constructs were cloned and checked for 
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expression.  These studies showed that deletions of > 100 amino acids did not yield any protein 
expression.  Therefore, a NEIL1 construct missing the C-terminal 100 amino acids 
(NEIL1CΔ100) was tested in crystallization studies.  This active construct was successfully 
overexpressed in E. coli, purified and crystallized (201).  Thus, this example clearly illustrates the 
potential utility of disorder prediction to increase chances for successful protein crystallization. 
Crystals were obtained for RluC after a 6-week crystallization period and the protein in 
the crystal was found to lack 88 residues from the amino terminus.  Further analysis showed that 
trace protease activity was likely responsible for the hydrolysis of the backbone.  Further 
crystallization trials using truncated RluC succeeded in 2–3 days (316).  PONDR predicts the 
removed region to be highly disordered, with a disorder–order boundary within 2 residues of the 
observed cleavage site.  Figure 20 shows this truncation from two perspectives: Figure 20A is a 
plot of the PONDR prediction with the removed region indicated and Figure 20B gives the order–
disorder prediction in the form of a bar with the crystallized region as indicated.  This bar-type 
representation is indicated here for later use. 
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Figure 20.  PONDR VL-XT predictions on the protein RluC.  PONDR VL-XT prediction output 
values plotted versus residue number, where the order-disorder threshold is indicated by the thin 
horizontal line at a score of 0.5 (A).  The region of this protein that was removed by proteolysis 
during crystallization trials is indicated by the thick gray bar.  In an alternative representation, 
PONDR VL-XT output scores are indicated in the upper bar of (B) in binary form where black 
bars (score ≥ 0.5) indicate disorder and white bars (score < 0.5) indicate order, with the sequence 
location indicated by the distance from the left end of the bar.  The region of the protein that was 
crystallized is shown by the lower bar of (B), coded white to indicate the region is ordered. 
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Crystallization of full-length β-recombinase required 6 months to produce small crystals.  
Analysis of the protein in the crystal revealed that 82 residues at the carboxyl terminal had been 
cleaved (317).  The removed region is predicted to be highly disordered by PONDR, with an 
order-disorder boundary within 10 residues of the cleavage site (data not shown). 
The removed regions of RluC and β-recombinase have not been convincingly 
characterized as completely disordered.  However, the extreme protease sensitivity of disordered 
regions suggests that these two proteins contain disorder, at least in the regions surrounding their 
cleavage sites.  Both of the cleaved loci are predicted to be disordered by PONDR VL-XT.  
Although neither of the termini of either protein is predicted to be completely disordered, removal 
of the bulk of the predicted disorder led to crystallization of both proteins. 
In practice, the fraction of residues predicted to be disordered at each terminus should be 
considered, not just long predictions of disordered at the termini.  If the terminal disorder 
represents a large portion of the predicted disorder in a protein, it is likely that removing such a 
region will improve a protein's crystallizability. 
Detection of ordered fragments 
Disorder prediction can be useful to identify the specific regions of proteins that may 
form rigid structures.  Figure 21 provides examples showing the relationship between PONDR 
predictions (upper bar) and the locations of structured fragments (lower bar) for a representative 
set of proteins. 
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Figure 21.  Comparison of PONDR predictions and protein fragments having 3-D structure.  
Proteins were chosen as representative of accurate and inaccurate PONDR VL-XT predictions.  
The PONDR VL-XT prediction for each protein is represented by the upper bar, where black 
disorder and white indicates order.  The lower bars represent determined structures with PDB 
accessions as labeled, where white indicates defined coordinates and black represents missing 
coordinates or divergent NMR structures.  Some examples are for proteins in isolation (1COK, 
1TSR, 1NRC, 2U1A, 1IMX, 1HCP, 1F3M A/B, 1F3M C/D, 1F7W), other structures are for long 
protein fragments in complexes with other proteins (mdm2 in 1YCR, 1I4E, 1QBQ) or nucleic 
acid (1JK1, 2RAM), some are for homooligomers (1TGK, 1G50, 1FBU, 1ICE), and some are for 
short protein fragments in complexes with other proteins (1FOS, p53 in 1YCR, 3SAK, 1DT7). 
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The predictions are obviously not perfect.  Short regions of predicted disorder are 
contained within ordered regions, and the fragment boundaries are often over- or under-predicted.  
Such inaccuracies can be partially attributed to disordered regions that are misclassified as 
ordered regions, as exemplified the c-fos and c-jun entries. 
Many ordered protein regions in PDB are involved in protein-protein or protein-nucleic 
acid complexes, yet these same regions are disordered in the absence of their partners.  By our 
definition, such regions should be classified as disordered, but such regions are typically 
misclassified as ordered in current data sets.  This adds noise to the data, which contributes to the 
observed error rates.  For example, DNA binding regions of proteins are often predicted to be 
disordered (264).  For some of these proteins experimental evidence has shown that such regions 
are disordered in the absence of DNA.  An example of this type is the c-fos/c-max leucine zipper 
DNA binding region.  Leucine zippers have been shown to be disordered in isolation from their 
zipper partner (318); therefore these regions of c-fos and c-jun are classified as disordered.  The 
1FOS crystal structure contains the leucine zipper dimerization regions of c-fos and c-jun, which 
are complexed to DNA.  The portions of these helices that make contact with the DNA are 
isolated from any other protein contacts, which suggest that these regions would be highly 
unstable in the absence of DNA, and indeed, these regions were predicted to be disordered.  
Similar behavior was also found for the c-Myc/Max leucine zipper DNA binding region.  
Furthermore, although c-Myc and Max were characterized by the well-defined, ordered structure 
in their tertiary complex with DNA (1NKP), the detailed structural characterization of unbound 
Max and c-Myc revealed that both proteins were highly disordered in their free forms and 
underwent mutual coupled binding and folding when their zipper domains interacted to form a 
helical coiled coil (Figure 22) (93, 319).  These examples show that comprehensive study of 
disorder predictions for regions involved in protein-ligand interactions may provide useful 
information for future attempts at identifying partners of intrinsically disordered protein regions. 
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Figure 22.  Intrinsic disorder-based interaction between c-Myc, Max and DNA. Both c-Myc and 
Max are intrinsically disordered in their unbound states (left side), but fold into coiled-coil dimer 
upon interaction with DNA (right side) (PDB ID: 1NKP).  c-Myc, Max, and DNA are shown as 
red ribbon, pink ribbon, and blue surface, respectively).  
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These results point to the importance of specific investigations of order–disorder 
boundaries to determine whether their prediction can be improved.  However, even without 
further refinement, disorder prediction can at least provide a useful starting point for structure 
studies by indicating possible locations of the ordered regions of proteins. 
Inclusion of binding partners 
While this paper has focused on the inhibition of protein structure determination by 
excessive amounts of intrinsic disorder, there are counter examples that do not fit this general 
trend, including structured proteins that do not form suitable crystals and disorder-containing 
proteins that do form suitable crystals.  Both of these features are discussed below in terms of a 
specific example. 
When a protein fails to crystallize or gives poor quality crystals, a common approach is to 
attempt to crystallize a homologue, often leading to a successful end result.  An interesting 
example is provided by attempts to determine the structure of protein phosphatase 1 (PP1) 
complexed with inhibitor 2 (I2).  When rabbit muscle PP1 was complexed with the rabbit I2 
protein, crystals that diffracted to ~ 4 Å were obtained (Tom Hurley, personal communication).  
However, when experiments were carried out using rat PP1 complexed with mouse I2, crystals 
were also obtained, but these diffracted to 2.5 Å, which was sufficient for 3D structure 
determination (320). 
The PP1:I2 complex also illustrates that proteins with substantial amounts of disorder can 
sometimes form crystals of sufficient quality for structure determination.  When not bound to PPI, 
the I2 protein is unstructured (320, 321).  Upon complex formation with PP1, three separate 
segments of I2 become structured, giving a total of 59 structured residues but with 154 residues 
that remain unobserved in the complex.  An NMR study of PP1 complexed with a large I2 
fragment, from residue 9 to 169, shows that 100 residues corresponding to two unobserved 
segments in the crystal indeed remain as a random coil in the complex.  Furthermore, large holes 
of sufficient size to accommodate models constructed for the IDP ensemble are observed for the 
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PP1:I2 crystal lattice (322).  This crystal structure is similar to those presented in Table 1, where 
a large disordered region can be accommodated by the crystal lattice if a sufficient number of 
ordered residues are present to support the lattice. 
Integration of disorder prediction with high throughput structure determination 
One use of PONDR in structural genomics would be to divide the target list into two 
separate pipelines: a structure pipeline, for whole proteins or protein domains for which standard 
structure determination would be appropriate (i.e., for highly ordered protein); and a disorder 
pipeline, for proteins or protein domains for which other methods of study would be appropriate 
(i.e., for highly disordered proteins).  Although a structure pipeline represents the current 
Structure Genomics methodologies, a disorder pipeline has not been implemented as of yet. 
The underlying rational for the PSI is that protein function can be inferred through 
knowledge of protein structure (259, 260).  Disordered proteins, however, are not encompassed 
by this view of protein function, including traditional ideas regarding protein flexibility, e.g. 
allostery and induced fit.  While much information can be gathered from disordered proteins 
through biophysical and biochemical methods, new models are required to translate this 
information into functional mechanisms.  The first step in the development of these new models 
is the accumulation of biophysical parameters from a broad range of disordered proteins.  
Through a centralized dataset of such information (e.g., DisProt database (16) or similar 
resources), generalities may emerge that will enable functional inferences, as is now possible with 
ordered proteins.  The lack of this accumulated information on disordered protein is a major block 
to understanding the mechanisms of disordered protein function. 
Disordered proteins can be analyzed by traditional biophysical methods including circular 
dichroism, infrared spectroscopy, fluorescence, various hydrodynamic studies, small-angle X-ray 
or neutron scattering, etc.  Studies using these methods provide a picture of the average 
conformational range of proteins (i.e., such methods when used in combination differentiate 
extended and collapsed disorder) (30, 31, 34, 313, 323).  Mapping protein disorder by the means 
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of limited proteolysis resolved through both SDS–PAGE and mass spectroscopy, which were 
successfully used to map disordered regions in XPA (13) and clusterin (12), would also be a 
generally applicable methodology.  These mapping studies localize disordered regions in terms of 
protein primary structure and can indicate the presence of structured domains, as in XPA (13), or 
indicate the presence of regions of secondary structure, as in clusterin (12).  A more complete 
picture of the conformational dynamics of disordered proteins could be obtained through the use 
of small molecule probes and cross-linkers that would indicate the time averaged spatial 
relationships of individual residues, although these techniques have yet to be explored in this 
context. 
A survey of disorder–function relationships for more than 90 proteins with 
experimentally determined regions of disorder of length ≥ 30 residues ascribed more than 25 
separate functions to the regions of disorder, with these functions falling into four broad 
categories: (i) molecular recognition, (ii) molecular assembly, (iii) protein modification, and (iv) 
entropic chains (7).  The molecular recognition category is especially interesting.  Molecular 
recognition by ordered proteins typically involves catalysis that can be described by the lock-and-
key paradigm, whereas molecular recognition by disordered proteins typically involves signaling 
with a DOT playing a key role.  Given that disordered regions have been implicated as the 
primary interaction regions in signaling events (9, 44, 47, 94, 264, 324, 325), these regions of 
proteins are prime candidates for use in proteomic binding assays.  Using protein chip technology 
(326), display of intrinsically disordered protein segments for screening against a host of gene 
products could prove to be advantageous in elucidating the web that underlies cell signaling.  
Thus, armed with biophysical and functional evidence, large advances in the understanding of 
disordered protein function could be made. 
Disorder prediction can be used to differentiate proteins that are likely to crystallize from 
proteins that are unlikely to crystallize or that are almost certain to not crystallize.  Proteins 
predicted to contain both ordered and disordered regions can be studied in both pipelines, using 
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disorder prediction as a starting point for any modification necessary to facilitate analyses (e.g., 
removal of disorder from structured domains and isolation of disordered regions).  Disorder 
prediction would also provide the basis for helping to identify structured and unstructured 
domains within multidomain proteins; such identified domains could then be recovered by 
genetic engineering and sent to their respective pipelines. 
The structure pipeline and disorder pipeline would collect ordered structure information 
and disorder structural information in complementary databases that would allow for concurrent 
study of some proteins in both contexts for the greatest possible efficiency and expediency.  
Regardless of whether an approach such as this is used, disorder prediction could aid selection 
and improvement of protein targets for the structure-determination pipeline through the filtering 
of disordered protein targets and isolation of ordered domains. 
Conclusion 
The impact of intrinsic disorder on the structure determination pipeline was studied 
retrospectively by examining missing density in the crystal structures and target progression in 
structural genomics relative to predicted intrinsic disorder.  Intrinsic disorder is tolerated to some 
extent in crystal structures, although extensive regions of intrinsic disorder are infrequent and are 
likely to require a sufficient relative proportion of ordered residues to support the crystal lattice.  
In fact, as shown in Table 1 and the associated references, large regions of apparently missing 
electron density in X-ray-determined protein structures in the PDB can arise from true intrinsic 
disorder, from mobile domains, from misannotation, or from unreported proteolysis, with 
intrinsic disorder accounting for about 30% of the mass of the protein in crystals containing the 
largest amounts of disorder.  Given the high solvent content (~ 50%) of typical protein crystals 
(Tom Hurley, personal communication), the capacity of protein crystals to accommodate such 
large amounts of disorder is not surprising.  This accommodation of disorder and the inaccuracy 
of disorder prediction (Table 2) combine to limit the ease of use of disorder prediction for 
filtering structural proteomic target lists.  
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Despite these limitations, the use of intrinsic disorder prediction for filtering targets is a 
viable method to improve the proportion of ordered targets in the structure determination 
pipeline.  Retrospective application of these methods additionally demonstrates that the effect of 
intrinsic disorder on structure determination is not only detrimental; increased success in 
purification is correlated with a higher proportion of predicted disordered residues, which agrees 
with recent observations (309).  For structure determination of individual proteins, prediction of 
intrinsic disorder can be an effective tool for tailoring proteins for structure determination.  
Though not developed to the extent to which automated analysis would be possible, consideration 
of prediction results on a protein-by-protein basis is certainly feasible.  For the time being, these 
methods will likely prove useful in a supplemental capacity.  That is, when difficult proteins are 
encountered, their PONDR predictions can be consulted to determine if they suggest an ordered 
region that might crystallize or a disordered terminus that could be easily removed.  In this way, 
PONDR predictions could be used to salvage regions of proteins for the structure pipeline and 
provide input for disorder analysis.  Finally, while this work focuses on the use of disorder 
prediction to facilitate structure determination, complementary approaches can be used to study 
those proteins and regions that fall outside the purview of direct structure determination methods. 
Several avenues are available to extend the current work.  One major challenge in 
studying intrinsic disorder from crystal structures is uncertainty in whether missing density is 
actually present in the crystal structure, or instead due to proteolysis or misannotation.  But, it 
may be possible to determine the presence or absence of missing directly from crystal structure 
data.  Specifically, protein crystal structures have a relatively narrow range of observed solvent 
contents.  Back calculation of the solvent content from the contents of the unit cell with and 
without inclusion of missing density regions may show whether presence or absence of missing 
density regions is more consistent with the allowable range of solvent contents.  While this 
method will not be sensitive enough for short missing density regions, it may be sensitive enough 
for large missing density regions.  Another avenue of further research is in structure pipeline 
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progress prediction, specifically development of stage specific predictors.  Model fitting results 
suggest that various stages of structure determination may have different, perhaps conflicting, 
attributes contributing to pipeline progression.  Stage focused models with a broader range of 
attributes will likely show better detection of targets that will progress through the structure 
determination pipeline. 
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IV. MOLECULAR RECOGNITION FEATURES  
The generality of IDP-mediated interactions is suggested by the large number of 
characterized DOT binding regions and the correlation between intrinsic disorder and regulatory 
functions.  Toward the end of estimating the prevalence of DOT regions and providing tools for 
helping to identify and characterize novel examples, several groups have developed predictors of 
DOT regions and related regions (111, 196, 234, 327–329).  Because these regions lack structure 
in the unbound state, all predictors developed to date are based on prediction from protein 
sequence.  Also, all predictors focus on regions that mediate interactions with proteins, thus so far 
ignoring the likely possibility that particular IDP subregions have evolved to bind DNA or RNA. 
Predictors of intrinsically disordered interaction regions 
A variety of methods have been developed to predict intrinsically disordered binding 
regions from sequence.  All of these methods have focused on regions shorter than typical folded 
domains.  This emphasis on short regions is based on the particular type region being modeled 
and complications in defining the interface of long DOT regions.  These predictors are based on 
two different views of these regions. 
In one view, these regions are modeled as short (on the order of 20 residues), DOT 
regions occurring within longer regions of intrinsic disorder, called Molecular Recognition 
Features (MoRF) (99, 111).  The inception of the MoRF model was the observation that some 
long regions of intrinsic disorder contained short predictions of order that correspond to regions 
responsible for molecular recognition (194).  In other words, while these regions had been 
demonstrated to be disordered when isolated from their binding partners, the sequence itself 
contains an intrinsic propensity to form structure, a propensity that is realized when binding to its 
partner.   Initial studies suggested that intrinsically disordered regions that formed α-helices in the 
bound state had particularly strong propensity to form structure, a property that was used to 
develop predictors of α-helix forming MoRFs (α-MoRFs) (111, 196).  Subsequently, a 
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generalized algorithm was developed for prediction of MoRFs regardless of the conformation of 
the bound state, MoRFpred (112).  Also, the independently developed ANCHOR predictor (327) 
is based on a definition of short,  DOT transitions regions similar to the MoRF definition. 
The other view of short intrinsically disordered binding regions is based on the idea of 
conserved, short (from 3 to no more than 15 residues), functional motifs, called Short Linear 
Motifs (SLiMs) (236).  The SLiM model is not directly dependent on intrinsic disorder in the 
unbound state.  However, instances of SLiMs have been shown to correspond closely to the 
MoRF model (237).  Generally, SLiM regions occur within longer regions of intrinsic disorder, 
but SLiMs show a propensity to be structured.  Regions flanking SLiMs have a propensity to be 
predicted to be disordered and flanking regions have compositions similar to intrinsically 
disordered proteins.  SLiMs, relative to their flanking regions, show an increased propensity to be 
predicted to be ordered and have compositions closer to ordered proteins.  Although SLiMs are in 
general correlated with regions of intrinsic disorder, it should be noted that some specific types 
and instances of SLiMs occur in an ordered context.  Several prediction methods are based on the 
SLiM model, including the ELM Server (234) and the Minimotif Miner (330).  Another 
prediction method, SLiMPred (328), while based on a SLiM dataset, takes a non-motif based 
approach to prediction of SLiMs. 
Datasets 
Ideally, development of a predictor of DOT binding regions would require only a positive 
dataset of known DOT binding regions and a negative dataset of other types of regions: folded 
domains and non-binding disordered regions.  Since the absence of known binding cannot be 
extrapolated to mean that a region cannot bind to any partner, it is difficult to assemble a negative 
dataset of non-binding disordered regions.  Different research groups have taken different 
approaches to addressing the problems associated with these types of regions.   
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α-MoRFs.  According to the MoRF model, MoRFs are short DOT regions.  Therefore, 
datasets for the various MoRF predictors were gathered from complexes in the PDB (278).  For 
the α-MoRF I dataset (14 α-MoRFs), helical fragments bound to longer, globular proteins were 
selected and verified for literature evidence of intrinsic disorder in the unbound state (111).  This 
approach was repeated for the α-MoRF II dataset, resulting in a lager set of MoRFs (196).  
Additionally, to further expand the dataset, homologous sequences to each MoRF-containing 
protein from UniProt were aligned to each MoRF region, and additional MoRF examples were 
selected at random from among those that align well to the MoRF region (54 MoRF + 48 
homologous MoRFs).  Control datasets were constructed from PDB monomers, i.e. sequences 
very unlikely to contain MoRF regions.  Development of the α-MoRFs predictors did not address 
false prediction of MoRFs within intrinsically disordered regions.  Again the problem is that if a 
given region predicted to be an α-MoRF is not known to bind to any partner, that does not mean 
that it does not bind to some yet to be discovered partner, so such false positives would be 
difficult to identify.  
MoRFpred.  A much larger dataset (840 MoRFs, 427 sequence unique clusters) was 
constructed by selecting bound fragments from PDB regardless of secondary structure and 
relaxing literature verification of intrinsic disorder in the unbound state (112).  For verification, 
fragments were analyzed by examining the relative bound and exposed surface areas (100), where 
this analysis indicated that fragment structures were consistent with disorder in the unbound state.   
Similar to α-MoRF predictors, a control dataset of monomers from PDB was used, but additional 
control sequences were taken from regions flanking MoRF regions.  The latter set of sequences is 
intrinsically disordered but assumed to be unlikely to contain MoRF regions.  Although there are 
some known exceptions to this assumption, e.g. the N-terminal MDM2 binding region of p53 is 
flanked by regions that interact with several other proteins (60), these types of exceptions were 
assumed to be rare. 
102 
 
ANCHOR.  Similar to MoRFs, the ANCHOR dataset is composed of short DOT binding 
regions (327).  All regions were verified to have experimental evidence of disorder in the 
unbound state in the literature.  The dataset constructed for ANCHOR optimization included an 
independent set of MoRF regions containing 46 examples, monomeric, ordered proteins, and bulk 
intrinsically disordered regions from the DisProt database (16).  Additionally, two validation sets 
were used: long DOT binding regions containing 28 examples and ordered protein that participate 
in complexes with other ordered proteins with 72 complexes in all.   
SLiMs.  Unlike the MoRF predictors and ANCHOR, the SLiMPred, ELM Server, and 
Minimotif Miner datasets are based on functional motifs rather than structural or functional 
propensities.  Consequently, the datasets used for these predictors do not rely on experimental 
structures.  For SLiMPred (328) and ELM server (234), the ELM database (331) is the primary 
dataset, which is a manually annotated set of functional motifs.  Minimotif Miner draws from 
several databases, as well as manually annotated motifs (330).  The control set for SLiMPred 
consisted of domains (as determined by a SMART (332) search) and non-SLiM residues of SLiM 
containing proteins (300 sequence unique SLiM containing proteins).  ELM server and Minimotif 
Miner do not use a control set per se, but rather use contextual filters to remove false positives 
after scanning for motifs. 
The datasets used in training and evaluation of predictors of DOT binding regions vary 
widely in terms of definition and experimental verification.  The α-MoRF predictors and 
ANCHOR used smaller, literature validated positive datasets, while the MoRFPred and SliMPred 
used much larger, but less well validated positive datasets.  Negative datasets vary even more 
than positive datasets, particularly with respect to treatment of disordered proteins, which are 
avoided in α-MoRF predictors, used in bulk in ANCHOR, and filtered for binding regions in 
MoRFPred and SLiMPred.  Ordered regions sets are similar across all predictors, consisting of 
monomeric, globular domains from PDB, except for MoRFPred, which additionally filtered out 
103 
 
structures with any missing residues that resulted in a significantly smaller ordered region dataset.  
Finally, ANCHOR also used additional evaluation sets: interfaces of structured proteins and long 
DOT binding regions. 
Architecture 
α-MoRFs.  The α-MoRF I (111) and II (196) predictors use similar architectures.  
Predictors are stacked with two stages: first, identification of potential MoRF regions, and 
second, classification of potential regions as MoRFs or non-MoRFs.  The first stage of the 
predictor identifies patterns in PONDR VLXT predictions that indicate the locations of regions of 
order propensity within longer regions of disorder.  The second stage distinguishes between  DOT 
binding regions and other causes of the disorder pattern, such as loops flanking a structured 
segment or false disorder predictions.  This predictor uses several sequence properties, including 
disorder prediction, secondary structure prediction, and hydropathy, which are averaged over the 
potential MoRF region, flanking regions, or both.  These attributes were used to train a quadratic 
discriminator and a neural network for α-MoRF I and II, respectively.  In both cases, averaging 
sequence properties over regions relative to the potential MoRF reduces the feature space 
sufficiently (6 features in both cases) to compensate for the limited number of examples. 
MoRFpred.  Unlike the α-MoRF prediction methods, which predict MoRFs per-region, 
the MoRFpred algorithm predicts MoRFs per-residue (112).  MoRFpred uses a support vector 
machine (SVM) with sequence and predicted features.  In addition to features considered in α-
MoRF predictors, the outputs of other prediction methods, such as B-factor and surface exposure 
prediction, and PSI-BLAST derived profiles were considered.  Features were aggregated over a 
series of sliding windows relative to the residue to be predicted, similar to region averaging in α-
MoRF predictors, and additionally features were calculated relative to a larger sequence window.   
Multiple sequence selection methods were used to select 24 features for the final SVM model.  
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SVM predictions were also augmented with alignments to MoRFs in the training set, which gave 
a small improvement to the true positive rate. 
ANCHOR.  The ANCHOR prediction method models DOT binding regions literally as 
disordered residues with a propensity to fold in a globular context (327).  The prediction score is 
a linear combination of the IUPred (333) disorder prediction score, the self-interaction energy, 
and the interaction energy gained in a globular context.  Energies are estimated as in IUPred, 
which are the averages of pairwise interaction energies between the residue of interest and a 
particular environment.  Model parameters were fit on short DOT binding regions, using globular 
proteins as a control set.  Concurrently, the rate of DOT binding residues in bulk intrinsic disorder 
was also coarsely minimized, which addresses the important objective of minimizing false 
prediction in intrinsically disordered regions in the absence of a disorder control set.  The set of 
long DOT binding regions was not used in training because the others observed that binding 
regions seem to be limited to discrete regions.  Rather than defining the discrete binding region 
within long DOT binding regions, they examined the behavior of the final predictor relative to the 
participation in the interface of each residue.   
SLiMPred.  MoRF predictors consider prediction context explicitly using region 
averaging.  Prediction context in the SLiMPred algorithm (328) is established through use of a 
bidirectional recurrent neural network (BRNN).  Connections in BRNNs link the internal state of 
an arbitrary number of previous and following residues to the prediction of the current residue.  
Inputs to the BRNN were protein sequence and predicted secondary structure, solvent 
accessibility, and structural motif (i.e. local conformation).    
Motif.  ELM Server (234) and Minimotif Miner (330) are based on matching motif 
patterns to regular expressions.  SLiM motifs are short (15 residues or less) and consequently 
many matches are expected to occur at random.  To reduce identification of false positive motif 
predictions or motif predictions that are irrelevant for a particular query, both methods apply 
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filters.  Two general types of filters are used: query sequence-based filters and database-based 
filters.  Query filters retain or remove predicted motifs based on predicted properties of a query 
sequence that favor or disfavor motif function, respectively.  For example, a motif found to be 
buried within a globular domain is likely to be a false positive motif prediction.  Other examples 
of query-based filters are domain prediction (234) and accessibility prediction (329).   Database-
based filters do not reduce false positives per se (330), but rather limit motif prediction to motifs 
that fit a certain set of criteria relevant to a given protein or query; these filters allow a subset of 
motifs to be selected based on information about the protein of interest.  For example, motifs that 
have been observed in a given taxonomic group or observed to be involved in a given biological 
process or cellular compartment can be selected (334).  Additionally, frequency statistics are used 
to rank matched motifs in reverse order of frequency of expected random matches (335).   
The architectures used for DOT datasets vary widely and the complexity of the approach, 
in terms of the number of parameters, is correlated with data set size.  The α-MoRF predictors 
have the smallest datasets and are relatively simple predictors, with a small number of parameters 
used in simple pattern recognition and a small statistical or neural network model.  The 
ANCHOR predictor has a comparable size DOT dataset as compared to the MoRF predictors, but 
uses a large number of interaction potentials.  However, potentials are derived primarily from the 
much larger ordered dataset, leaving only three free parameters trained on binding regions, 
making ANCHOR arguably the simplest DOT binding region predictor.  MoRFPred and 
SLiMPred have relatively complex architectures with a large number of parameters, but the 
dataset used to train these parameters is much larger than the other predictors.  In terms of 
parameters, motif-based predictors are among the most complex since they require a pattern for 
each type of motif, in addition to instance sequences. 
Also, all prediction architectures consider the larger sequence context when predicting 
DOT binding regions, though each in a different way.  The α-MoRF predictor and MoRFPred 
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consider context explicitly by considering features averaged over windows of the potential 
binding region and in the flanking sequence.  ANCHOR uses an extended window to measure the 
disordered context and intra-sequence interaction propensity of a target residue.  Context is an 
intrinsic feature of the bidirectional recurrent neural network (BRNN) architecture used by 
SLiMPred.  Finally, the sequence filters used in motif-based prediction establish the, for example, 
order-disorder context of predicted motifs through domain prediction. 
Evaluation 
Prediction methods.  The common evaluation for all prediction methods was the true 
positive rate for DOT binding regions and the false positive rate for monomeric globular proteins.  
However, this evaluation ignores some important cases, namely intrinsically disordered regions 
that do not contain binding sites and interfaces of ordered proteins.  The former is a difficult 
problem common to many bioinformatics prediction tasks due to lack of annotation not being 
equivalent to a negative annotation, and is dealt with in different ways by MoRFPred and 
ANCHOR authors.  ANCHOR authors also addressed the ordered interface control, and 
additionally they evaluated performance on long DOT binding regions. 
The primary evaluation of prediction methods can be grouped into two types of 
approaches relative to the positive and negative datasets: (i) a small, high-confidence positive set 
of DOT binding regions and a negative set of ordered regions and (ii) a large positive set of DOT 
binding regions and a negative set of disordered regions.  Approach (i) is in some senses an easier 
problem than approach (ii) for several reasons.  The larger positive datasets are likely to be 
noisier than the smaller, literature verified datasets.  Also, disordered negative datasets are noisier 
than ordered negative datasets; many unannotated binding regions may occur in disordered 
regions but not in ordered regions.  Finally, several of the prediction methods make use of 
disorder prediction directly as a base attribute, meaning that the there is a greater contrast 
between positive and negative datasets when using a ordered negative dataset as opposed to a 
disordered negative dataset.   
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The α-MoRF I and II predictors and ANCHOR use approach (i) to determine accuracy 
and both demonstrate high accuracy on their respective datasets.   MoRFPred and SLiMPred used 
approach (ii) to determine accuracy.  For a negative set, MoRFPred used non-MoRF residues 
from MoRF containing proteins, which contain both ordered and disordered residues, and 
residues flanking MoRF regions, which are likely to be disordered.  Similarly, SLiMPred used 
non-SLiM/non-domain residues for a negative set.  The demonstrated accuracies of these 
algorithms on these sets are markedly lower than in the cases of α-MoRF I and II predictors and 
ANCHOR.  This difference in evaluated accuracy is due to differences in the evaluation sets and 
does not reflect relative predictor accuracy.  
Additionally, both MoRFPred and SLiMPred authors compared their respective 
performances to other MoRF predictors, which also showed the same reduced accuracy on these 
datasets relative to their own datasets.  In the case of the SLiMPred dataset, ANCHOR showed a 
very similar accuracy to SLiMPred.  In the case of the MoRFPred dataset, α-MoRF predictors had 
a very low false positive rate, but also a low true positive rate.  The latter is not unexpected given 
the limited scope of these predictors.  ANCHOR showed a good true positive rate on this dataset, 
but also a very large false positive rate. 
Finally, ANCHOR was evaluated on additional datasets.  The fraction of bulk disorder 
residues predicted to be binding regions was reported to be about 45%.  Due to the ambiguity 
noted above, it is not known what the real target quantity should be, and it is constrained to be 
less than 50% during training.  ANCHOR was also evaluated on long DOT binding regions.  
Rather than predicting these long regions to be a single binding region, ANCHOR predicts them 
to be composed of several binding regions.  This segmentation of prediction suggests that long 
disordered binding regions are composed of several independent short binding regions.  This idea 
is supported by data for the p27-Cyclin/CDK complex, which shows that the prediction score is 
correlated with the number of atomic contacts per residue (327). 
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Motif methods.  It is generally believed that motif methods have a high false positive rate 
due to the low complexity of short motif patterns may frequently find matches at random.  
However, accuracy evaluations of the kind performed for prediction methods have not been 
reported for motif based methods, either with or without filtering.   This is at least in part due to 
different nature of the two methods; supervised predictors require a positive examples and 
negative examples for training that can also be used for evaluation, but motif-based methods 
require only positive examples.  Filter approaches partially mitigate the high false positive rate of 
motif methods.  Sequence filters remove hits that might occur within a structured protein and 
motif filters remove hits that arise from irrelevant motifs, in terms of cellular or functional 
context. 
An indirect evaluation of unfiltered motifs predictions confirms that the false positive rate 
is indeed quite high (336): (i) eukaryotic-specific domains are predicted at the same rate across 
eukaryotes, bacteria, and archaea, and (ii) motifs with narrow roles are predicted to occur 
frequently.  Motif prediction filter methods adequately address the source of error (i), since 
source organisms are generally well annotated.  Performance of filter methods for the source of 
error (ii) depends greatly on the completeness of the relevant functional annotations; filters will 
function properly for well annotated proteins, but will return false positives and negatives for 
missing and incorrect annotations, respectively. 
Comparison 
The SLiMPred authors compared their algorithm to ANCHOR and showed that the two 
algorithms have similar prediction accuracy – with nearly identical ROC curves – to ANCHOR 
across all examined datasets including long disordered regions (328) with two exceptions.  When 
applied to secondary structure sub-sets, the two prediction methods have similar accuracies for all 
subsets except for polyproline II helices, where SLiMPred shows a markedly higher accuracy.  
Also for prediction of ordered SLiMs and disordered SLiMs, i.e. SLiMs predicted to be ordered 
or disordered respectively, the algorithms showed similar accuracy on disordered SLiMs, but 
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SLiMPred demonstrated much higher prediction accuracy on ordered SLiMs.  It should be noted 
that IUPred was used to classify ordered and disordered SLiMs, and that the IUPred prediction 
score is one of ANCHORs three primary attributes.  Therefore this test is inherently biased 
against ANCHOR prediction, however it does beg for an evaluation of experimentally verified 
ordered and disordered SLiMs by ANCHOR and SLiMPred. 
In terms of best accuracy, there is no direct comparison of all methods, so no definitive 
statements can be made.  Inferring from similar evaluation accuracy of SLiMPred and ANCHOR 
(328) and the comparison of MoRFPred and ANCHOR (112), it is likely that MoRFPred has the 
highest prediction accuracy, with a slightly lower true positive rate but a much lower false 
positive rate than either ANCHOR or SLiMPred.  The α-MoRF predictors do not compare to the 
other predictors in terms of their true positive rate, due to the limited scope of these algorithms.  
However, they do compare well in terms of their false negative rates, which is somewhat 
surprising given that intrinsic disorder was not included in their negative training sets. 
An extensive comparison of DOT binding region prediction and motif prediction 
demonstrates a useful synergy between these approaches (336).  For many type of ligand binding 
motifs from the ELM database, two thirds of motif instances overlap with ANCHOR-predicted 
DOT binding motifs, but less than a fifth of predicted ligand binding motifs ANCHOR 
predictions.  This result suggest that DOT binding region may make an effective sequence filter 
of motif predictions by greatly increasing specificity with only a modest reduction in recall.  The 
observed overlap is highly dependent of the type of motif.  Motif instances occur in predicted 
ordered regions, disordered regions, or mixed environments.  Motif instances occurring in 
disordered regions generally show a high overlap with ANCHOR predictions, and motif instances 
in mixed order-disorder regions show a good but reduced overlap with ANCHOR predictions.  
Those few motif instances in ordered regions show very little overlap with ANCHOR predictions, 
which suggests that predictions of ordered regions would be an appropriate filter for these motif 
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types.  Also, secondary structure of the bound motif instance effects filtering efficiency; overlap 
with ANCHOR predictions is increased for motifs that form helix and somewhat decreased for 
motifs that form extended structures.  Finally, DOT binding region prediction can enrich 
predicted motifs in biologically relevant predictions, as demonstrated by overlap between 
predicted nuclear receptor box motifs and ANCHOR; ANCHOR filters nearly four fifths of the 
predicted nuclear receptor box motifs in the human proteome and the remaining predicted motifs 
are enriched in relevant Gene Ontology annotations: nuclear localization, regulation of 
transcription, transcription cofactor, and protein binding annotations. 
There are commonalities between the reviewed methods, but also important differences.  
The differences are particularly important for datasets and evaluation methods.  Some aspects of 
these differences may be leveraged in order to create improved predictors and extend biological 
knowledge.   
Conclusions 
Current DOT prediction methods are varied in every aspect: from the underlying model 
to the construction of datasets to methods of evaluation.  The similarity between the MoRF, 
SLIM, and motif models has been demonstrated.  But these models, which all address short DOT 
regions, have yet to be reconciled with long DOT regions, and a combined model of short and 
long regions would result in expanding available data for predictor development.  Also, control 
datasets need to be refined and expanded, particularly for non-interacting IDP control sequences.  
Finally, the complexity observed for some IDPs with respect to multiple binding suggests that 
prediction of binding sites from single sequences may be too limited. 
Expanding DOT Datasets 
Several surveys of DOT binding regions have shown that these regions come in various 
lengths: from short segments of a few residues to long regions of a size comparable to small 
folded domains.  Given the length heterogeneity of DOT binding regions, the current generation 
of predictors would seem to address only a portion of the prediction problem, which is the 
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prediction of short DOT regions.  Indeed, coverage of long disorder-to-order binding regions by 
current predictors has been shown to be quite poor (327, 328).  However, it may be the case that 
long DOT binding regions are composed of multiple, short DOT binding regions, which is 
suggested by one analysis (327).  Additional experimental evidence is required to verify if 
decomposition of long DOT binding regions to a combination of short regions is a generally valid 
approach.  However, this approach is consistent with the observation that long DOT regions have 
a low amount of intra-protein buried surface area in bound structures (100, 337), with much of the 
buried surface occurring between the disordered protein and its partner.  These observations 
suggest that the use of short regions for predictor development may be an adequate, in the 
absence of additional experimental evidence. 
Many additional DOT examples may be available from the PDB, but to date, there has 
not been a comprehensive study of the DOTs present in protein structures in the PDB.  Reported 
surveys, which rely on comparative analysis, have been limited by availability and reliability of 
reference monomer structures. Though limited, these surveys suggest that DOTs may be a 
common feature in protein complex structures.  Therefore, a survey of DOTs independent of 
reference monomers could potentially reveal many more novel DOT regions.  Model-based 
analyses, particularly molecular dynamics and thermodynamic stability analysis (i.e. COREX), 
are theoretically capable of performing a survey of DOTs in the PDB.  However, the 
computational demands and practical limitations make such a survey intractable.  Alternatively, 
structural analysis has been shown to be a promising method for analyzing complex structures for 
the presence of DOTs (e.g. surface area analysis (100)).  However, current methods are only 
applicable to entire proteins, and are applicable to protein containing both DOT and structured 
regions.  At least one alternative method designed for the classification of DOT and structured 
regions has been developed (51), but not well characterized.  Also, other methods developed for 
flexibility analysis, such as normal mode (105) or mechanical (103) analyses, may be repurposed 
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for identification of DOT regions.  Development and characterization of new analyses will help to 
greatly expand DOT region datasets. 
Another avenue for expanding DOT datasets is to combine the datasets of the current 
methods.  All methods reviewed here relied on short binding regions as a positive dataset for 
training.  Generally, complex structures were used to determine the bounds of the DOT binding 
region and disorder in the unbound state was verified to differing extents, where larger datasets 
precluded strict validation used for smaller datasets.  For motif based methods, short motif 
patterns and instances were collected from the literature and are consequently well verified.  
Although there exists some overlap between these sources of short DOT binding regions, a union 
of these two sources would significantly increase the size of available datasets.  Such an approach 
should consider that some minority of motifs are known to be or likely to be in a structured 
context or themselves structured prior to binding. 
It is a general concern that some ordered regions might be included in constructing 
datasets of DOT regions.  Some smaller datasets require literature evidence of intrinsic disorder 
in the unbound state (111, 327), but this approach is prohibitive for construction of larger 
datasets.  Although structural analysis can give an indication of the order-disorder state of the 
isolated monomer (100), this analysis assumes a structure is available and only applies to the 
fragment present in the structure.  The more important question is if the fragment is structured or 
disordered in the context of the parent protein.  Several ELM motifs types seem to occur within a 
disordered context (237), but the binding regions themselves are not necessarily disordered.  In 
other words, a DOT region may occur as an unstructured loop or tail of a structured domain, e.g. 
14-3-3 binding region of serotonin N-acetyltransferase (186).  Such regions lack the disordered 
context of typical MoRFs and are difficult for predictors that rely on this context for prediction.  
It is clear that these types of DOTs do not fit neatly into the MoRF model and may require 
treatment as a special case.  However, the increased performance of SLiMPred on these regions, 
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relative to ANCHOR, suggests that special treatment may not be necessary given the appropriate 
attributes and prediction architecture.  Similar difficulties arise when constructing an appropriate 
control set. 
Control Datasets 
A control set is necessary for training prediction methods and for estimation of the rate of 
false prediction.  In the motif-based formulation of the DOT binding region prediction problem, 
sets of motif instances that do not bind to associated domains are very difficult, if not infeasible, 
to construct.  For this reason, there has been no direct quantification of the false positive rate of 
motif-based methods.  Prediction methods however require a control set for training, and 
generally two types of protein regions are used, ordered and disordered.   
For ordered sequences, generally only sequences with monomeric structures are used.  
Generally complexes are avoided due to the possibility that one or more of the partners is 
disordered in the unbound state, except where additional evidence is available to indicate the 
complex is formed by ordered monomers.   
Intrinsically disordered regions are problematic for the same reason that motif control 
datasets are problematic; it is generally not known whether a given disordered region binds to any 
partners.  One approach to this problem is to assume that interaction regions are sparse and that 
residues outside of known binding domains do not interact with partners, which is the approach 
taken by MoRFPred and SLiMPred.  However, the interaction map of p53 (60), one of the most 
intensely studied proteins in the human genome, shows that its interactions are tiled over the 
disordered termini.  While p53 may not be a prototypical protein, this observation does call into 
question the assumption of sparsity of interaction regions within disordered segments.  
Improving Prediction Model 
The example of p53 raises two complications with prediction of intrinsically disordered 
binding regions.  Under the current model of DOT binding region prediction, a residue is 
predicted to be a binding residue if it interacts with any partner.  This implies that the correct 
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prediction for the N-terminus of p53 – according to the interaction map which shows that the N-
terminus is tiled with interaction sites, would have nearly the entirety of the N-terminus predicted 
as binding residues.  While correct under the current model, such a prediction is not practically 
very useful for novel proteins and may be misleading.  The other complication is one-to-many 
binding regions, in which the same region or overlapping regions bind to multiple partners.  That 
is, it is tempting to interpret predictions of binding sites as binding to a single partner, but 
multiple partners may be involved.  Current predictors do not address this complication.  Motif-
based methods do not suffer these complications, but do not predict novel binding sites. 
A more useful and transparent prediction model would decompose a protein into non-
binding sites and competent, perhaps overlapping, binding sites.  However, direct application of a 
single sequence approach to decomposition represents a large increase in algorithm sophistication 
and complexity, and would not address the case of one-to-many binding.  An alternative approach 
that may be more effective would be to combine binding site prediction with knowledge of a 
particular partner.  Such an approach has been applied in the analysis of peptide binding domains, 
such as SH3 (338) domains.  This approach considers the peptide binding site of the peptide 
binding domain to predict peptide sequences compatible with binding to a particular instance of a 
peptide binding domain.  In a sense, this method constructs a pseudo motif, which is dependent 
on the details of the binding partner.  Another approach is to consider coevolving residues 
between two binding partners in the form of mutual information (339).  Generalization of these 
types of methods, in combination with consideration of context provided by the current 
generation of binding site predictors, may be the way forward to the next generation of DOT 
binding region prediction. 
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